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Abstract 
Many recent biomedical therapies were made possible due to the advantages of cell 
culturing within a bioreactor. These enclosed systems encourage higher cell density with 
increased production rates of proteins including enzymes and antibodies. The systems are 
also capable of three dimensional (3D) culturing, which is highly relevant to research aimed 
at thick tissue and organ regeneration.  
With the mentioned applications of bioreactor culturing a commercial market for bioreactor 
systems and related parts has developed. However the expensive costs and skill 
specialisation associated with these commercial systems hinder researchers beginning and 
expanding bioreactor related studies. The aim of this research was to produce a low-cost 
drip-perfusion bioreactor system that was simple and flexible in design and operation, and 
would be scalable in numbers.   
This rationale was followed when selecting bioreactor components and fabrication 
techniques. The components were sourced from general laboratory stock or outsourced to 
inexpensive fabricators. The fabrication techniques refrained from intricate processes and 
were inexpensively replicated. These fabricated components were assembled in-house.  
Validation of our drip-perfusion bioreactor was performed over 28 days with murine 
fibroblasts (3T3s) cultured in 3D polymer scaffolds. These scaffolds were fabricated by 
thermally induced phase separation using poly(DL-lactide) or fused deposition modelling 
using polylactide in a consumer-grade 3D printer. The 3D cultures did not require passaging 
and maintenance was limited to media change every two to three days. Culturing cells on 
poly(DL-lactide) scaffolds saw an 18-fold increase in calculated cell numbers within 5 days. 
Fluorescent staining of 28 day cultures, in the polylactide scaffolds, indicated an increase not 
only in cell activity but also in the development of tissue-like cell masses. These structures 
formed cell bridges between layered orthogonal polymer fibres indicating true 3D cell 
proliferation instead of two dimensional surface cell culture. 
The harvested cultures indicated areas of limited cell proliferation, located on the superior 
surface of the scaffolds. It appeared that the impact force of the medium dripped onto this 
scaffold region restricted cell proliferation possibly due to shear stress. Therefore, future 
work should address this issue of fluid handling. Optimisation could involve redesigning the 
scaffold architecture to uniformly distribute the medium and limit occlusion caused by dense 
cell growth.  
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In summary, the user-friendly designed and inexpensively fabricated drip-perfusion 
bioreactor achieved scalable system numbers to simultaneously maintain multiple three 
dimensional cell cultures over long-term durations. 
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1.0 Literature review  
1.1. Summary and significance 
1.1.1. Introduction  
A bioreactor can be described as a system that is capable of sustaining a cell culture within a 
dedicated environment. Its overall purpose is to harness the available biochemical processes 
to synthesise practical products or adapt them into processing systems.  
Cell types commonly cultured in bioreactors include bacterial cells, plant cells or animal cells 
depending on the purpose of the bioreactor system (Casablancas, et al., 2013; Hohe & Reski, 
2002; Jain, et al., 2011; Lee, et al., 2009; Rausch, et al., 2013). The cellular and biochemical 
processes of cells within the bioreactor are influenced by the type and design of the system, 
the nutrients and gas delivered to the cells in culture, and the supporting scaffold structures 
for three dimensional (3D) cell growth (Alvarez‐Barreto, et al., 2011; Calderón, et al., 2011; 
Mozo, et al., 2012). The bioreactors also vary in their size, ranging from the larger sized 
systems deployed in communal water bodies to bench-top sized constructs and simple 
syringe sized systems (Bartnikowski, et al., 2014; Bijonowski, et al., 2013; Leong, et al., 2013). 
Depending on the bioreactor type the nutrient and gas delivery may be incorporated into 
medium delivery or provided to the cells through separate channels. There are systems that 
require a scaffold to support 3D cell proliferation and culture. The architecture of this scaffold 
also influences the flow of the medium and influences regions of cell growth (Arrigoni, et al., 
2012; Bartnikowski, et al., 2014; Leite, et al., 2011; Lesman, et al., 2010).  
When considering the bioreactor designs, construction, size, supporting scaffolds and 
variability there are numerous possible combinations of these system parameters. 
Subsequently this review will focus on bioreactor systems applicable to protein production 
and tissue engineering.  
Pharmaceutical companies aim to optimise protein production and large scale manufacturing 
of their therapeutic products. A necessary requirement for these protein products involves 
post-translational modifications (PTMs) such as phosphorylation, glycosylation and 
acetylation which ensures correct protein conformation and functionality (Mann & Jensen, 
2003). On the other hand tissue engineering aims to regenerate in vitro human tissues and 
organs for their subsequent transplantation in vivo (Langer & Vacanti, 1993). Currently both 
of these fields use mammalian cells. This commonality of successfully maintaining dense 
three dimensional (3D) cell cultures depends on the bioreactor design but may be 
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complicated. These bioreactor designs can incorporate electronic components and digital 
sensors such as electrodes connected to neural networks, where variable levels of oxygen, 
carbon dioxide and pH are digitally monitored (Buczkowska, et al., 2010; Harper & Yi, 2013; 
Wang, et al., 2012). Although monitoring of these parameters has advanced the bioreactor 
system designs, the integration of digital and electronic components increase design and 
operating complexities; which in turn requires training and qualified personnel for 
maintenance and support. Opposed to these complex versions of bioreactors are the 
bioreactor systems that are user-friendly yet highly specific in purpose (Harris, et al., 2007; 
Tan, et al., 2010). Some of these user-friendly systems are difficult and costly to fabricate due 
to the need of specialised equipment such as plasma cleaners and handheld plasma 
treatment devices. Furthermore, bioreactors have shown research success in literature 
however their translation into clinical applications has been limited. Designing a bioreactor 
system that addresses the issues of design and fabrication, flexibility and scalability of design, 
potential to translate to clinical settings and user-friendly operating procedures will be 
examined in this project. The current research and challenges involving bioreactor designs, 
bioreactor applications and 3D cell culturing are discussed in the following sections.  
 
1.2. Biomedical applications for bioreactors 
Bioreactors have been successfully used in protein production and tissue engineering, with 
both applications using high density cell cultures (Bartnikowski, et al., 2014; Bijonowski, et 
al., 2013; Casablancas, et al., 2013; De Jesus & Wurm, 2011; dos Santos, et al., 2013; Jayapal, 
et al., 2007; Rausch, et al., 2013). These two application topics will be discussed in the 
following sections. 
1.2.1. Protein and antibody production 
Recombinant eukaryotic protein production provides the pharmaceutical industry products 
for drug manufacturing (Ihssen, et al., 2010; Jayapal, et al., 2007; Kim, et al., 2012; Wurm, 
2004). Furthermore recombinant eukaryotic protein research has shown insights into the 
changes of protein function and structure after post-translational modification (Mann & 
Jensen, 2003; Öberg & Hedfalk, 2013; Soufi, et al., 2012).  
The most convenient system for the mass production of proteins is the Escherichia coli 
bacterial bioreactor system. E.coli was first used in combination with a basic bioreactor 
constructed of a hollow fibre membrane to produce the enzyme β-lactamase (Inloes, et al., 
1983). This bacterial cell was shown capable of producing high levels of various eukaryotic 
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proteins by fusing exogenous deoxyribonucleic acid (DNA) to the β-Galactosidase gene 
(Casadaban, et al., 1980; Miroux & Walker, 1996). Although capable of producing large 
quantities of proteins with minimal costs, they come with disadvantages. Many eukaryotic 
proteins require post-translational modifications (PTM) which control their functioning status, 
localisation and molecular interactions at certain times during their life span (Soufi, et al., 
2012). Naturally bacterial cells are incapable of eukaryotic PTM but E. coli has been 
transformed with a glycosylation system transferred from Campylobacter jejuni (Wacker, et 
al., 2002). However the ability to stably glycosylate requires further optimisation (Ihssen, et 
al., 2010). Glycosylation, acetylation and phosphorylation PTM processes have been 
transferred into E.coli, although further work is also required for the many other PTMs that 
eukaryotic cells undergo including common biotinylation, methylation, sulfation, 
deamidation, ubiquitinaiton and disulphide bond folding processes (Bessette, et al., 1999; 
Mann & Jensen, 2003; Sørensen & Mortensen, 2005).  
Another cell type capable of protein production is yeast Pichia pastoris. This cell type has 
been used extensively in fermenter bioreactors and produces high yields of protein (Öberg & 
Hedfalk, 2013). These fermenter systems provide efficient aeration and agitation, increasing 
oxygen levels in the cell culture which is essential for driving the aldehyde oxidase 1 promoter 
preceding the gene of interest (Cereghino, et al., 2002). High oxygen levels have shown high 
protein yields beneficial to both research studies and commercial production of 
pharmaceutical compounds (Nyblom, et al., 2007). However, there are still issues with 
recombinant protein synthesis within P. pastoris. Studies have indicated aggregation of 
synthesised proteins due to high production of recombinant proteins and in turn causes 
problems with correct conformation, localisation, functionalization, and protein-protein 
interaction (Bonander, et al., 2005; Öberg & Hedfalk, 2013).  Additionally, there are still 
problems with perfect glycosylation of recombinant human proteins produced in P.pastoris 
due to differences in Golgi apparatus enzymes between these cell types (Nett, et al., 2011).  
Furthermore antibody production has been researched for diagnostic applications notably 
leukaemia and lymphoma (Ritz & Schlossman, 1982), passive immunisation treatment 
against diseases including HIV-1 (Prince, et al., 1991; Voronin, et al., 2014), and used against 
addiction drugs such as methamphetamine (Owens, et al., 2011). The production of 
antibodies can be performed by hybridoma cells; a fusion between a myeloma cell and a T 
cell (Uchiyama, et al., 1981). Hybridoma cell culture in fed-batch cultures (see Section 1.4) 
and perfusion bioreactor systems have shown increases in protein yield and functional 
antibodies with correct post-translational modification (Bessette, et al., 1999; Inoue, et al., 
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2011; Irani, et al., 2002; Jain, et al., 2011; Sørensen & Mortensen, 2005). However there are 
issues with recombinant protein production in hybridoma models such as lactate by-product 
that limit cell culture duration and impinge on protein quality; furthermore the cell cultures 
consume high quantities of glucose and glutamine but exhibit low growth rates and low cell 
concentrations (Dietmair, et al., 2011; Omasa, et al., 2010; Sunley & Butler, 2010).  A notable 
study by Kim & Lee (2007) conducted in batch bioreactors limited lactate production by 79% 
by down regulating lactate dehydrogenase (LDH) with LDH-A siRNA (short interfering 
ribonucleic acid) in cultured recombinant Chinese hamster ovary (CHO) cells. Another 
approach to improving protein yields from hybridoma culture involved changing the cell 
culturing environment. A study by Jain, et al. (2011) showed a polyacrylamide-chitosan 
cryogel matrix, used in a perfusion bioreactor in continuous mode (see Section 1.4), was 
capable of culturing murine hybridoma cell lines over 60 days with four-fold higher antibody 
production than 2D flask culturing. Although this system increased antibody production by 
removing by-product build up, it required over 17 litres of media during 60 days of cell 
culturing. Running the bioreactor system would involve high media consumption but this 
system could be optimised to reduce medium usage, in turn reducing the financial load 
involved.  
1.2.2. Tissue engineering 
Tissue engineering and regenerative medicine (TERM) consists of several disciplines including 
cell biology, materials science, mechanical engineering and nanotechnology. TERM 
researchers investigate the ability to regenerate and repair damaged and failing tissues and 
organs, especially to accommodate the donor shortages of tissue and organ patient waiting 
lists. Although the field is relatively new, tissue engineering gained momentum after Langer 
and Vacanti (1993) reviewed the existing literature which stimulated research in subfields 
investigating cell types to biomaterials to bioreactor designs to the final tissue or organ being 
produced (Auger, et al., 2013; Bartnikowski, et al., 2014; Cao, et al., 2004; Heckmann, et al., 
2007; Hutmacher, 2000; Perrier-Groult, et al., 2013; Reichert, et al., 2012; Xie, et al., 2010; 
Yan, et al., 2012; Zhang, et al., 2010).  
Specific mammalian cell types are required for testing scaffolds and bioreactor designs as 
well as producing the targeted tissues and organs. Mesenchymal stem cells (MSCs) have been 
a popular cell choice due to their plasticity and ability to differentiate into various lineages 
including osteoblasts, chondrocytes, adipocytes, fibroblasts, stromal cells and astrocytes 
(Drugmand, et al., 2012; Nishi, et al., 2013; Oshiki, et al., 2013; Xu, J., et al., 2011). Second to 
this are fibroblasts due to their easy maintenance and robust nature. Additionally, fibroblasts 
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have been studied and established as cells capable of synthesising, secreting and depositing 
extracellular matrix (ECM) components, in particular collagen I, collagen III and fibronectin in 
wound healing situations (Lambert, et al., 1992; Mutsaers, et al., 1997). These ECM proteins 
contribute to the building of latticework for further cell-cell interactions (Eckes, et al., 1993; 
Eckes, et al., 2000). These fibroblast characteristics have made this mammalian cell a 
candidate for testing bioreactor systems (Bartnikowski, et al., 2014; Domingos, et al., 2009; 
Leite, et al., 2011).  
As discussed in regards to protein production and tissue engineering there are multiple cell 
types available such as bacterial, insect, mammalian and plant. All these types have been 
validly cultured in bioreactor systems (Drugmand, et al., 2012; Nishi, et al., 2013; Oshiki, et 
al., 2013; Xu, J., et al., 2011). However, the importance of mammalian cells in TERM related 
models and their ability to synthesis correct protein confirmations in protein production 
make it a potential candidate for this research of culturing cells in bioreactors.   
 
1.3. Bioreactor cell culturing 
Work conducted in the fields of protein production and tissue engineering can largely benefit 
from denser viable cell cultures; this process can be provided by bioreactor cell culturing and 
outperforms traditional flask surface culturing. Although 2D surface culturing has been the 
traditional approach for studying cells (Carrel & Burrows, 1911) and has involved numerous 
refinements (Evans & Kaufman, 1981; Freshney, 1986, 2005), the requirements for surface 
area, incubator space and reagents for culturing high cell numbers is not comparable to the 
reduced reagent volumes and space requirements of 3D cell cultures. These aspects are 
relevant for expanding anchorage-dependent cells into a high density culture.  
Regarding protein production, higher cell numbers increases cellular machinery which in turn 
raises the protein synthesising rate and increases the amount of output product for 
purification and pharmaceutical drug production. These mentioned conditions could be 
accommodated by initially providing a cell culturing environment conducive to viable high 
density cell culture over extended durations; this approach lies within the capabilities of a 
bioreactor system.  
Concerning tissue engineering the work is focused on regenerating and reparation of 
injured, diseased and failing tissues and organs where the majority of products (e.g. bone, 
cartilage, heart, etc.) are inherently 3D (Bian, et al., 2011; Jun, et al., 2013; Lee, et al., 2009; 
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Ott, et al., 2008; Reichert, et al., 2012). Reproducing these structures requires dense cell 
culturing in three dimensions which again lies within the capabilities of a bioreactor system.  
 
It is important to note that the environment provided by the bioreactor has direct influence 
over the ability to nourish cells into a dense and heavily populated culture, appropriate for 
both protein engineering and TERM related uses. One influential aspect is the internal static 
or dynamic environment of the bioreactor, which will be discussed briefly in the following 
section.  
 
1.3.1. Three dimensional cell culturing under static and dynamic conditions  
A static environment is the prominent approach for traditional 2D cell culturing, and involves 
the passive use of the cell culturing medium within a gas permeable container (Freshney, 
1986, 2005). Conversely, a dynamic environment actively aerates the medium and 
encourages its movement through the cell culture (Bartnikowski, et al., 2014; Bilgen, et al., 
2006; Lewis, et al., 1993; Van't Riet & Tramper, 1991). This dynamic environment can be  
typically accommodated by a bioreactor system (Sailon, et al., 2009; Zhao & Ma, 2005). 
Either approach of static or dynamic environment can provide a successful three dimensional 
cell culture, but it would be dependent on the desired dimensions and the physiological cell 
niche that is being emulated. Studies of natural niches have shown cells prefer a location 
within a 400 μm distance to nutrients and gas exchange, generally provided by 
microvasculature within the human body (Auger, et al., 2013; Carmeliet, 2000).  
Studies found that using a static approach for 3D cell cultures (with dimensions greater than 
400 μm) led to culturing conditions limited in interior gas exchange; and these low 
oxygenated and hypoxic regions increased in intensity towards the internal most regions of 
the 3D stem cell and osteocyte cultures (Volkmer, et al., 2008; Zhao & Ma, 2005). Murine, 
embryonic stem cell studies highlighted the differences in genetic expression when both 
approaches were used and compared amongst 2D and 3D cell cultures under static and 
dynamic environments (Liu, et al., 2006). The results reported that a 3D dynamic culture of 
embryonic stem cells increased expression of ECM-related genes when compared to both 3D 
and 2D cultures expanded within static environments. Another study investigating 
osteogenic cells in 3D scaffolds reported similar results when the dynamic environment 
approach was compared to the static approach (Rath, et al., 2012). Rath et al. showed a 
favourable increase in alkaline phosphatase expression and calcium deposition in the 
dynamic culturing conditions over the static conditions. The same study showed the 
  
8  Chapter 1: Literature review and introduction   
decreased gene expression and decreased cell numbers from the static approach were both 
reversed when the 3D culture was transplanted into a dynamic environment. 
A precursory study to this research project (Leo Leung Honours unpublished data, 2011), 
investigated three dimensional cell cultures under both static and dynamic conditions which 
resulted in similar outcomes to those mentioned above (Rath, et al., 2012; Zhao & Ma, 2005). 
Lower cell density in the static 3D culture was found as opposed to the higher cell density 
found in the dynamic 3D culture. The static conditions involved mesenchymal stromal cells 
(MSCs) seeded at a ratio of 50:1 with microvascular endothelial cells (MVECs), onto poly-DL-
lactic acid scaffolds (11 mm Ø, 1.6 mm height), and cultured in the wells of a 12 well plate 
with 5 mL of growth medium (changed every two to three days). At the end of the three week 
experiment a 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay 
showed only the superior surface of the 3D cell culture to be metabolically active (Fig. 1-1). 
It was reasoned there was an inability for passive oxygen diffusion into the inferior most 
locations of the 3D culture, being situated further than the 400 μm distance from the air-
liquid interface. Furthermore, it was suggested this hypoxic effect within the internal and 
inferior regions of the scaffold developed and led to cell atrophy and cell necrosis leaving the 
lower scaffold regions unpopulated during the latter part of the experiment.  
 
 
Figure 1-1 Stained metabolic activity of a static environment co-culture of mesenchymal 
stromal cells (MSCs) and microvascular endothelial cells (MVECs) in a poly-DL lactic acid 
(PDLLA) scaffold.  
Images depicting a MTT stained section of a seven day, static environment, 3D co-culture of 
1.15x106 MSCs and 2.75 x104 MVECs within the polymer scaffold. A) an image from the side 
view of the 3D co-culture section and indicates cellular metabolic activity located at the 
superior surface of the section. B) an image from a top down view, depicting the cellular 
metabolic activity located to the left side of the scaffold, and dispersed over the remaining 
superior surface area. Scale bar represents 5 mm.  
 
A 
 
 
B 
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Opposed to this static environment outcome, the precursory study involving three 
dimensional cell cultures expanded in a dynamic environment of a prototype drip-perfusion 
bioreactor, suggested a denser 3D cell culture shown by cellular metabolic activity from an 
MTT assay. These two week co-cultured results indicated an intense stain near the peripheral 
surfaces of the 3D polymer scaffold culture as well as less intense staining within the internal 
regions of the cultured scaffold. (Fig 1-2).  
 
Figure 1-2 Stained metabolic activity of a two week, MSC and MVEC co-cultured poly-DL 
lactic acid scaffold in a dynamic bioreactor environment.  
Image depicting a MTT stained section of a 3D co-culture of 3 x107 MSCs and 3 x106 MVECs within 
a PDLLA scaffold. The section was taken from the centre of the cylindrical scaffold (24 mm Ø, 12 
mm height), and although depicted cellular metabolic activity in the central region, the most 
intense regions were the edges of this sectioned scaffold. Scale bar represents 10 mm. 
 
These studies support the argument for 400 μm access distance for nutrient and gas 
exchange (Auger, et al., 2013; Carmeliet, 2000) and indicates the influence of a three 
dimensional environment on cell expansion and gene expression involved in 3D cultures (Liu, 
et al., 2006; Rath, et al., 2012). These factors will contribute to this project’s parameter list, 
favouring the use of a dynamic environment due its advantages of aerating medium while 
actively delivering the nutrient rich-fluid through the 3D culture.  
Although the dynamic approach outperforms the static in both gene expression and cell 
expansion literature showed hypoxia eventually occurred due to dense clustering of 
internally located cells, which ultimately restricted access to external nutrients and gases 
(Melchels, et al., 2010; Volkmer, et al., 2008). Eventual hypoxia was also indicated from the 
precursory honour’s study as the interior regions, though less intensely stained, showed less 
interior cellular activity towards the end of the culturing period.  
It should also be noted that specific levels of hypoxia has reported to cause important 
influential changes such as differentiating precursor cells via chondrogenesis or osteogenesis 
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(Duval, et al., 2012; Karageorgiou & Kaplan, 2005), angiogenesis in cancer and tissue 
engineering (Carmeliet, 2000; Chiu & Radisic, 2010), and instigating wound healing (Malda, 
et al., 2007; Sen, 2009).   
 
This project investigates high density, anchorage-dependent, mammalian cells cultured in 
three dimensions. A dynamic environment will be utilised, but due to the limitations of the 
study, hypoxia can only be minimised to encourage cell expansion; this will be attempted by 
using a particular scaffold design. The scaffold is an existing requirement for adherent 3D cell 
attachment and expansion, and with an appropriately fabricated internal architecture the 
scaffold can provide greater access to gas exchange and add to the culturing longevity of the 
3D cell culture.  
 
1.3.2. Scaffolds 
Bioreactors used for TERM studies, investigating both in vitro and in vivo tissue and organ 
regeneration, commonly involve a scaffold to support 3D dense cell growth. There is a 
dedicated field of research focused on scaffold related aspects including design material, 
functionality, fluid interaction, architecture and fabrication methods (Cao, et al., 2004; 
Hutmacher, 2000; Hutmacher, et al., 2001; Karageorgiou & Kaplan, 2005; Lesman, et al., 2010; 
Werkmeister & Ramshaw, 2012; Yan, et al., 2012; Yeatts, et al., 2013). Scaffold design is also 
capable of influencing cell-cell and cell-scaffold behaviours (Bartnikowski, et al., 2014; Eckes, 
et al., 1993; Mutsaers, et al., 1997) and will be also covered briefly in the following sections.  
1.3.2.1. Biomaterials  
Scaffolds can be fabricated from natural or synthetic biomaterials, each type having 
respective advantages and disadvantages (Hutmacher, 2000; Karageorgiou & Kaplan, 2005).  
Natural biomaterials for scaffold construction include silk fibroin, collagen and ceramics 
(Harkin, et al., 2011; Sell, et al., 2009). Such biomaterials provide mechanical strength and 
functionality, which can be tailored as per requirements. Porosity, pore interconnectivity and 
surfaces of the scaffold are also optimised via fabrication parameters, and the scaffold can 
be designed to degrade in vivo over time leaving the newly formed tissue-construct. Ceramics 
are usually fabricated via high temperature sintering creating scaffold constructs with pore 
diameters of 400 to 600 μm with 80% porosity for osteogenesis murine models (Damien, et 
al., 2003; Karageorgiou & Kaplan, 2005). Collagen is naturally expressed and relatively 
conserved between mammalian species limiting inflammatory response when implanting 
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collagen based scaffolds into mammalian models (Gordon & Hahn, 2010). Silk fibroin derived 
from the silkworm Bombyx mori has been used in studies where its fabricated mechanical 
strengths were examined and its capability for ophthalmic tissue engineering was 
investigated (Altman, et al., 2003; Bray, et al., 2012; Yan, et al., 2012).   
Synthetic biomaterials approved by Therapeutic Goods Administration (TGA) and US Food 
and Drug Administration (FDA) include poly(lactic-co-glycolic acid) (PLGA), poly-L-lactic acid 
(PLA), poly-DL-lactic acid (PDLLA), and poly-Ɛ-caprolactone (PCL). These biopolymers have 
been successfully used either alone or in combinations to give specific rates of degradation, 
tensile and compressive capabilities and varied substrate surfaces of scaffold for cell culturing 
(Engelhardt, et al., 2011; Gredes, et al., 2012; Hutmacher, et al., 2001; Melchels, F. P. W., et 
al., 2011; Perrier-Groult, et al., 2013).  
Although both natural and synthetic biomaterials can be fabricated to desired dimensions 
and porosity, polymeric materials are inexpensively manufactured and readily available 
making them applicable for large scale production.   
1.3.2.2. Scaffold fabrication procedures 
There are numerous methods to produce polymeric scaffolds that are robust and reliable yet 
inexpensive. These include (but are not limited to), fused deposition modelling (FDM), phase 
separation, melt electrospinning, photolithography, emulsification or their combinations 
(Cao, et al., 2004; Farrugia, et al., 2013; Hutmacher, 2000; Khademhosseini & Langer, 2007).  
Melt electrospinning is a versatile technique capable of using different polymeric materials 
to fabricate scaffolds. The polymer is supplied to a reservoir, heated, and then a voltage is 
applied to the melted polymer, creating a ‘melt’. This melt is ejected as a stream of fluid 
through a capillary which accelerates towards a grounded collector below allowing the 
solvent to evaporate while depositing a charged polymer on the plate. The distance between 
the capillary and grounded collector allows the charged melt to whip laying down spun layers 
of fibres (Yoshimoto, et al., 2003). This method can be controlled to fabricate porous 
architecture to nanoscale measurements and to specific patterns when guided by computer 
(Chung, et al., 2010; Farrugia, et al., 2013; Sell, et al., 2009). Electrospun nanoscale porous 
architectures encounter the cell culturing issue of micron sized cells attempting to migrate 
through nanometre sized pores. This issue can be addressed with electrospraying 
concurrently with electrospinning, where cells are sprayed from a second nozzle onto the 
forming polymer scaffold on the collector plate (Naito, et al., 2011), however optimisation is 
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still required. Overall the versatility of this fabrication technique can produce scaffold 
architectures with pore structures ranging from nanometres to centimetres in diameter. 
Scaffolds produced from this technique would be suitable for testing new bioreactor designs 
and demonstrating bioreactor versatility.   
FDM combines a computer program’s accuracy with the mechanical processing of polymer 
melt extrusion to 3D print continuous filaments of a chosen polymer. Due to the 
computational control, the scaffold matrix can be laid down according to the designer. This 
approach has shown to be quite robust, reliable and capable of maintaining cell culture 
(Bartnikowski, et al., 2014; Reichert, et al., 2012; Reichert, et al., 2010). Currently the 
biomaterial properties combined with this technique produces scaffolds suited for structural 
tissues and has seen success with bone and cartilage culturing (Hutmacher, et al., 2001). This 
technique requires specific machinery and computer software knowledge; however, the 
advances in 3D printing systems and dramatic decrease in costs make this technique a 
possible scaffold fabrication process.  
Thermally induced phase separation (TIPS) involves dissolving the biopolymer into a solvent 
which undergoes a phase change at a certain temperature, the polymer is then precipitated 
from the heterogeneous mix in a controlled manner leaving a negative image of the solvent’s 
crystal structure. Removal of the solvent by, for example, vacuum sublimation or leaching 
into water, leaves behind a highly interconnected and porous scaffold (Cao, et al., 2004). 
Through optimisations, porosity levels gained can be in excess of 95% allowing easier media 
dispersion for cell proliferation (Cao, et al., 2004; Liu & Ma, 2009). At this porosity level, these 
TIPS scaffolds are flexible and can be applied to soft tissue engineering (Leo Leung Honours 
unpublished data, 2011).  
The techniques outlined above are only a few of those currently available (Melchels, F. P. W., 
et al., 2011) for fabricating scaffolds for bioreactor testing. Preferable selection criteria of 
fabrication procedures would include resource efficiency, rapid processing times and 
inexpensive costs.  
1.3.2.3. Scaffold modifications 
Synthetic biomaterials such as PLA and PLGA are generally hydrophobic (Rezwan, et al., 2006) 
and when used as scaffolds for cell culturing surface modification is required to assist with 
cell attachment. There are many surface modification techniques available: from simple 
treatments, such as priming with culturing media containing exogenous ECM protein(s) to 
the complex engineering of cell adhesion receptor (integrin) binding motifs into the scaffold, 
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such as amino acids arginine-glycine-aspartic acid (RGD) to facilitate cell attachment onto 
large scaffolds (Alvarez‐Barreto, et al., 2011; Anderson, et al., 2011; Eckes, et al., 1993; Kolhar, 
et al., 2010; Miyagi, et al., 2011). Other studies have successfully immobilised growth factors, 
such as VEGF and angiopoietin-1 onto scaffold surfaces which assisted in organising H5V 
murine embryonic heart endothelium into vascular like structures (Chiu & Radisic, 2010). 
When considering scaffold surface functionalization an approach inexpensive in time and 
costs is ideal. 
1.3.2.4. Scaffold architecture 
Scaffolds can be fabricated with architecture traits such as random pore interconnectivity 
and pore diameters of 50 to over 200 μm such as those fabricated by phase separation (Fig. 
1-3), and digitally designed geometric, 45 μm to 2 mm pore lengths achievable with FDM (Fig. 
1-4) (Hutmacher, 2000; Leong, et al., 2003). These porous architectures become routing 
channels for delivering cell rich media into the scaffold for cell attachment to the pre-
functionalised scaffold pore surfaces. Additionally, these pores provide routes for 
transporting nutrient and gas infused media to the adherent cells in the scaffold and also 
routes for metabolic waste products to exit the 3D culture. However, the balance between 
cell culture proliferation within the pores, and media delivery and removal through the pores 
must be considered as high density cell growth will result in pore obstruction and excessive 
media flow rates will affect cell function and may detach cells from the substrate entirely 
(Bancroft, et al., 2003; Sailon, et al., 2009). These aspects of pore architecture are required 
to be analysed when selecting a fabrication protocol for producing scaffold models.  
 
 
A B 
C D 
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Figure 1-3 Pore sizes fabricated by thermally induced phase separation of combined 
polymers polylactic acid (PLA) and poly-L-lactic acid (PLLA) 
Image was adapted from (Pavia, et al., 2013). The images obtained from scanning electron 
microscopy showed scaffold cross sections with exposed pore sizes. Polymers used for scaffold 
fabrication involved a ratio of PLA to PLLA: (A) 90/10, (B) 80/20, (C) 70/30 (D) 60/40. Scale bars 
shown in white indicate 200 μm. 
 
Figure 1-4 Scanning electron microscopy showing variation in pore architecture of high 
density polyethylene scaffolds fabricated by fused deposition modelling.  
Image was adapted from Leong, et al. (2003) showing variations in scaffold micro-architectures 
produced using different raster gap settings (RGS) between parallel fibres and laydown patterns; 
RGS=200 μm (A) 0°/90°, (B) 0°/60°/120°, (C) 0°/36°/72°/108°/144°; RGS=500 μm (D) 0°/90°, (E) 
0°/60°/120° , (F) 0°/36°/72°/108°/144°.  
 
Fabricating scaffolds to be cultured with anchorage dependent cells for the purpose of testing 
a bioreactor design, should involve consideration of scaffold traits such as architecture, 
biomaterial and fabrication processes; ideally these traits should include ease of fabrication, 
able to be mass produced and be cost efficient.  
 
1.4. Current bioreactor designs 
The modes of bioreactor operation are dependent on the type of processing required: batch, 
fed-batch, and continuous operation. Batch operation commonly involves protein production 
in a bacteria model where the chamber contains the cell culture along with limited nutrients 
B A 
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(Fig. 1-5 A)(Chiu, et al., 2007). This mode is a contained system where all the contents (such 
as cells, nutrients, culturing media, by-products, and gas) are removed at the end of the 
bioreactor culture and the system is reset for the next culture run. Expanding on this 
contained system, fed-batch operation introduces an option of continuous feeding allowing 
control of nutrient levels during cell culturing (Fig. 1-5 B). Additionally, fed-batch operation 
has been optimised to predict and direct nutrient input to accommodate cell culture 
consumption while maximising production, however this approach still requires emptying 
when the chamber fills with cell culture and/or expressed product (Dhir, et al., 2000; Roubos, 
et al., 1999). The third mode is the continuous bioreactor mode with constant input and 
output of nutrients and product, respectively and can be maintained for prolonged periods 
of time (Fig. 1-5 C)(Van't Riet & Tramper, 1991). Most TERM bioreactors favour the 
continuous mode which constantly provides fresh nutrients to the cell cultures; protein 
production systems have been known to use the three mentioned modes (Arrigoni, et al., 
2012; Bijonowski, et al., 2013; Dahlin, et al., 2012; dos Santos, et al., 2013; Jain, et al., 2011; 
Leong, et al., 2013; Rausch, et al., 2013; Sadeghi, et al., 2011; Wang, et al., 2012).   
 
 
Figure 1-5 Modes of operation for a stirred-tank bioreactor 
(A) The batch operation mode involves filling the chamber with nutrient-rich media and cell 
culture. The nutrients are metabolised by the cells until the media is exhausted. The chamber is 
emptied and readied for the subsequent cell culture. (B) Fed-batch mode expands on the batch 
mode process by adding fresh media during the culture. This operation mode controls the feed 
rate stabilising cell expression and limiting proliferation and preventing cell quiescence. (C) 
Continuous mode provides fresh medium constantly to the cell culture. Cells express metabolic 
products which are removed continuously from the system. This mode of operation allows the 
bioreactor to run for extended durations.  
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The bioreactor systems related to tissue engineering will be discussed here and although this 
research is based on in vitro bioreactor systems it would be noteworthy to briefly mention in 
vivo bioreactors. In vivo bioreactors use the internal bodily environments of living subjects; 
typically the ovine and murine models are used in research to regenerate damaged tissue 
(Fig. 1-6) (Beier, et al., 2010; Fiegel, et al., 2010; Kneser, et al., 2006).  
In such models the cells were cultured on a scaffold and implanted adjacent to a femoral 
artery that was manipulated to pass through the scaffold, forming an arteriovenous (AV) loop. 
 
Figure 1-6 Intra-operative view of a hydroxyapatite/β-Tricalcium phosphate matrix 
scaffold containing an arteriovenous (AV) loop within a sheep subject 
The image was adapted from Beier, et al. (2010). This implant, located in the sheep’s groin, 
contains a matrix scaffold isolation chamber infiltrated with fibrin glue. A microsurgically created 
AV loop (indicated by the arrow) is placed within the chamber and then subsequently embedded 
in the hybrid composite.  
 
 
The success of in vivo bioreactors in these studies relied on the cultured scaffolds being 
integrated into the subject’s body providing routes for nutrient and gas exchange. However, 
when considering translation to clinical applications this design is reliant on the host being 
capable of integrating exogenous material into their bodies and their limited reaction to the 
foreign body. Variability between patients would be expected as each patient would present 
different postoperative recovery rates and possible complications depending on existing 
medical conditions (Qian, et al., 2013; Wang, et al., 1997). However, the regeneration of 
tissue and organs in vitro under controlled conditions potentially circumvents this problem 
of uncertainty.  
The in vitro bioreactors offer controllable conditions and current designs emulate 
homeostasis providing basic necessities of its in vivo counterpart: optimal temperature, gas 
exchange, nutrient delivery and waste removal (Alvarez‐Barreto, et al., 2011; Bartnikowski, 
et al., 2014; Bijonowski, et al., 2013; Dahlin, et al., 2012; Zhang, et al., 2010).  
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Despite the numerous designs there are a lack of bioreactors that have translated to 
biomedical applications (dos Santos, et al., 2013). Differing ideas regarding cell culturing 
within bioreactors have promoted designs from wavy-walled bioreactors to rotating wall to 
perfusion systems, each having inherent merits and demerits (Bartnikowski, et al., 2014; 
Bilgen, et al., 2006; Bueno, et al., 2005; Dahlin, et al., 2012; Ishikawa, et al., 2011; Lewis, et 
al., 1993).  
1.4.1. The wavy-walled bioreactor 
Some bioreactor designs create hydrodynamic forces by media-construct interactions which 
mimic the natural forces found in the body. One such design is the wavy-walled bioreactor 
which creates hydrodynamic forces throughout the media, which in turn act on the cell 
culture construct causing shear and stress forces (Fig. 1-7). These forces influence 
extracellular matrix production in cells, and have been suitable for cartilage constructs 
(Bilgen, et al., 2006; Bueno, et al., 2005). 
 
 
Figure 1-7 Front elevation (A) and (B) top elevation cross-section of a wavy-walled 
bioreactor 
The image was adapted from Bilgen, et al. (2006). The mouth of the flask is enclosed with a 
stopper plug penetrated by four needles. Scaffolds are threaded onto the opposite needle ends. 
The stir bar provides convection in the medium assisted by the contours of the walls. The radius 
of the bioreactor is given as average radius, Ravg = 3.35 cm.  
 
1.4.2. The rotating wall bioreactor 
The rotating wall bioreactor is a part filled cylinder rotating about a horizontal axis producing 
hydrodynamic forces suspending the culture in an induced microgravity (Fig. 1-8) (Lewis, et 
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al., 1993; Nishi, et al., 2013). Recent results demonstrated the use of a rotating wall 
bioreactor to reconstitute capillary networks of foetal mouse liver after 10 days of culture 
creating a vascularised sample of 3000 µm by 2500 µm dimensions (Ishikawa, et al., 2011). 
Nishi, et al. (2013) reported the ability to culture vascularised bone constructs within a 
rotating wall bioreactor using MSCs and endothelial cells derived from MSCs seeded onto a 
polylactic acid (PLA) scaffold. However this bioreactor design is limited by the same medium 
convection properties that encourage its 3D cell culture. The force of the convection current 
would change when moving from the outer radius to the inner radius and centre of the 
chamber. A study showed internal distribution of nutrients to be limited due to the inability 
of the convective forces to reach the interior of the scaffold (Sikavitsas, et al., 2002). 
Expanding on this, the shearing forces created in the medium require consideration regarding 
stimulation to the internal scaffold while not overly taxing the external scaffold regions 
(Hansmann, et al., 2013).  
 
 
Figure 1-8 Rotating-wall bioreactor prior to cell culturing 
The image was adapted from (Lewis, et al., 1993). The chamber is spun by a 24 Volt direct current 
motor simulating a microgravity environment. An air pump supplies oxygen to the membrane 
covering the central axis and the gas is diffused into the chamber.   
 
1.4.3. The perfusion bioreactor 
Another design is the perfusion bioreactor which in which media flow is actively guided 
through the scaffold construct to maintain the cell culture (Alvarez‐Barreto, et al., 2011; 
Bartnikowski, et al., 2014; Dahlin, et al., 2012; Rausch, et al., 2013). For this bioreactor type 
the scaffold pores and porosity are important traits and influence delivery routes. The 
perfusion approach has allowed for perfusion seeding, where cells are infused into the 
scaffold upon initial culturing (Bartnikowski, et al., 2014; Kitagawa, et al., 2006; Timmins, et 
al., 2007). The perfusion system has numerous designs where tubing, pumps and media flow 
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rates, scaffold housing, and other parameters vary according to each investigation group (Fig. 
1-9)(Dahlin, et al., 2012; Jain, et al., 2011; Wendt, et al., 2009). Hence, it has been typical for 
each researcher to optimise individual configurations per bioreactor before experimentation. 
Perfusion bioreactors have been used in protein production, more specifically antibody 
production as well as tissue engineering research (Al-Rubeai, et al., 1992; Auger, et al., 2013; 
Fassnacht, et al., 1999; Hansmann, et al., 2013; Jain, et al., 2011; Wang, et al., 2012; Yeatts, 
et al., 2013).  
Of the bioreactor designs mentioned for culturing anchorage dependent cells, the perfusion 
concept is simplest. Generally this design involves less components required for medium 
movement such as the central spinning axis of the rotating wall bioreactor or the need for a 
wavy-wall design integrated into the culture chamber (Bilgen, et al., 2006; Nishi, et al., 2013; 
Sailon, et al., 2009). Less moving components contributes to a sturdy bioreactor design and 
detracts from maintenance. However, perfusion designs are known to experience a challenge 
with shear stress as medium is driven through the chamber and culturing scaffold (Bancroft, 
et al., 2003; Dvir, et al., 2006; Gardel, et al., 2013). A balance is required between delivering 
enough nutrient and gas-rich medium into larger sized culturing scaffolds and limiting change 
in cell function and cell detachment due to medium flow through these scaffolds.  
 
Figure 1-9 Perfusion bioreactor fabricated from medical grade 316 stainless steel 
The image was adapted from Dahlin, et al. (2012). (A) The assembled bioreactor schematic 
displays the scaffolds integrated into the chamber housed by O-rings. The medium reservoir and 
flow chamber are defined as incorporated traits of the design. (B) The two components, base and 
lid, are held together by stainless steel bolts and wingnuts. The system is capable of culturing cells 
in the medium volume range of 35 to 145 mL.  
 
Depending on the different bioreactor designs these forces may be harnessed to emulate 
native environments of articulating joints or simulate forces experienced by structural tissues 
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which respectively encourage cartilage or bone formation (Bueno, et al., 2005; Nishi, et al., 
2013). Bioreactors are also designed to specifically favour certain physiological processes 
such as blood vessel formation and growth, heart valve regeneration and tendon and 
ligament regeneration (Bijonowski, et al., 2013; Lee, et al., 2009; Nishi, et al., 2013; Wang, et 
al., 2012). As expected, the various parameters and the need for specific customised systems 
have led to user-specific bioreactor designs, which require extensive technical expertise and 
are difficult to manufacture. These bioreactor complexities require simplification to provide 
researchers with a user-friendly model and a possible translation to clinical and commercial 
work.  
 
1.5. Current bioreactor costs and operability  
Commercially available bioreactors are developed as a complete product with the intention 
of prompt use after purchase. These bioreactor ‘turnkey’ solutions may require initial system 
configuration and training, in addition to the cost price. Current market prices for 
commercially built bioreactors range from $5,000 USD for used equipment to $150,000 USD 
for newer bioreactors equipped with electronic and digital monitoring and control systems 
(EuipNet, 2015; LabX.com, 2015). These prices may be acceptable for well-funded research 
groups and high profile companies, but for researchers restricted by a limited budget these 
prices may be exorbitant values. 
In regards to operability there are commercial products that require technical familiarity with 
over one hundred pages of operating instructions (New Brunswick, 2013; New Brunswick 
Scientific, 2010; Harvard Apparatus Regenerative Technology, 2013). Understanding these 
manuals would require a devoted time frame to learning the commercial product before use. 
Although these equipment manuals are technically involved, these are full systems 
comprising of the bioreactor infrastructure, and computer control and monitoring platform.   
Commercially available bioreactor equipment become more costly as the bioreactor system 
tends towards a complete and standalone bioreactor infrastructure. Although with additional 
components the overall system increases in complexity, and in turn increases in knowledge 
are required for system understanding and correct operability. Hansmann, et al. (2013) 
postulated that the complexity to good operability was a constraint in commercial bioreactor 
development. Expanding on Hansmann’s reasoning, reducing costs and improving operability 
could include using existing laboratory equipment (cell culturing incubators) and available 
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laboratory items (cell culturing flasks, syringes) to stand in place of expensive components of 
commercially developed bioreactor systems. This rationale would assist researchers in 
reducing costs, providing suitable bioreactor operability and accessing research areas of 
tissue engineering and protein production.  
1.6. Conclusion 
The use of bioreactors have improved understanding and optimised procedures for research 
topics involving protein and antibody production, tissue and engineering, and regenerative 
medicine. Bioreactors have provided the ability to cell culture in high densities and 
subsequently harness the biochemical processes available within this environment. However, 
current bioreactor systems tend to favour either high-tech and complex, or simple but rigid 
designs.  
A novel design that is straightforward in operation, constructed with minimal expense, 
requires light maintenance, and capable of translating to clinical applications or industrial 
applications provides researchers and clinicians with beneficial options. A bioreactor system 
thus designed will appeal to users across a spectrum of biomedical backgrounds and address 
the current shortcomings. 
 
1.7. Hypothesis 
It was hypothesised a novel drip-perfusion bioreactor system could be economically built to 
be scalable, simple in design and operation, and capable of maintaining in vitro three 
dimensional cell cultures.  
 
1.8. Aims 
Three aims were derived to address the research hypothesis: 
1) To design a drip-perfusion bioreactor system that is scalable, involves minimal cost 
and is simply operated. 
 
2) To fabricate, integrate and construct a viable drip perfusion bioreactor using 
inexpensive materials and replicable techniques. 
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3) To validate the fabricated drip-perfusion bioreactor by maintaining viable in vitro 
3D fibroblast cultures on synthetic biopolymer scaffolds.  
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2.0 Materials and methods 
2.1. Introduction 
This chapter outlines the materials and methods used in the scope of this project. 
Modifications to any of the methods or alterations to materials used are provided in the 
respective chapters. The methods were performed at room temperature (23 °C).   
 
2.2. Design philosophy and drip-perfusion schematics  
A novel bioreactor concept was designed with traits of: adaptability for cell biology and 
bioengineering research; simple operating procedures; inexpensive construction costs; and 
light maintenance. This bioreactor design was based on the perfusion concept. The simplicity 
of the perfusion design was conserved and streamlining the concept involved minimisation 
of mechanical components such as excess motors and actuators.  
The design of the bioreactor chamber involved successive steps beginning with reduction of 
medium volume, then repositioning the culturing scaffold above the medium (Fig. 2-1 B). 
Subsequently, the concept of medium perfusion through the scaffold was conserved by 
integrating medium feed outlets situated above the scaffold in the design (Fig. 2-1 B). This 
adapted concept involved feed outlets dripping medium onto the scaffolds and then medium 
perfused into the scaffolds, producing a drip-perfusion concept (Fig. 2-1 C). The medium was 
designed to be delivered ultimately by gravity. 
 
Figure 2-1 Adaptation of a perfusion bioreactor design 
(A) General perfusion design housing a culturing substrate within the chamber, serviced by 
medium supply tube and medium removal tube. (B) First design adaption of the perfusion system 
incorporated a larger chamber and situated the culturing substrate above the medium. (C) 
Second design adaption integrated gravity dripped and perfused medium onto and into the 
scaffold, respectively. (D) Third adaptation involved recirculation maximising medium usage.  
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Medium use was designed to be resource efficient and included recirculating the excess drip-
perfused medium collected in the reservoir to the feed outlets (Fig. 2-1 D); this action was 
designed to be handled by a peristaltic pump with a control valve to direct medium within a 
medium recirculation loop.  
The system design integrated gas permeable tubing into the medium loop allowing 
oxygenation of the medium during recirculation. Gas exchange and pressure equilibrium 
within the chamber was accommodated by an air filter incorporated to service the chamber, 
which itself was an inexpensive centrifuge tube in the design. Key components servicing the 
chamber were integrated into a bioreactor head design and included an air filter, medium 
return tube, and the drip-feed outlets (Fig. 2-2 A). The drip feed outlets were designed in a 
pentagonal formation to uniformly distribute medium onto a scaffold (Fig. 2-2 C). The 
suspension tray was porous yet sturdy to support a polymer scaffold (Fig. 2-2 D). The 
bioreactor head was designed to be inserted securely into the centrifuge tube chamber (Fig. 
2-2 B).  
 
Figure 2-2  Design of the drip-perfusion bioreactor head  
(A) The cast bioreactor head design integrated key components: waste return tube, air exchange 
tube and media delivery via gas permeable tubes ending as drip-feed outlets. The scaffold 
suspension tray would be supported by lightweight arms. (B) The bioreactor head would be cast 
to fit into a 500 mL Corning® centrifuge tube (Sigma-Aldrich, Australia). (C) Top elevation of the 
bioreactor head design depicting drip-feed outlets arranged in a pentagonal formation including 
a central hole. (D) Top elevation of the scaffold suspension tray design allowing excess medium, 
from the scaffold, to pass through the tray into the reservoir below.  
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A medium insertion line for the system was designed to connect to the control valve. The 
design also included a medium withdrawal line from the 3-way control valve connected to a 
hand pump (Fig. 2-3). Medium control was regulated by a combination of a 3-way control 
valve and the peristaltic pump or the manual hand pump.  
An air trap was integrated into the design to confine excess gas circulating through the media 
loop. These design schematics were then converted to computer aided designs (CAD) and 
used in the bioreactor fabrication processes.       
 
Figure 2-3  Media handling design of drip-perfusion bioreactor  
The design provided two driving forces within the system regulated by a single 3-way valve. An 
air trap was included in the system situated before the six feeding tubes. (A) The flow arrows 
marked yellow indicated the intake of medium directed by the valve and driven by the pump into 
the chamber. (B) The red marked medium flow designated the closed medium loop, driven 
exclusively by the peristaltic pump and delivered medium into the chamber via drip-perfusion 
onto and into the scaffolds. (C) The blue arrows indicated the open circuit design allowing 
withdrawal of medium using the manual hand pump while still allowing the peristaltic pump to 
cycle medium into the chamber. 
Air trap 
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2.3. Fabrication of computer aided designs 
The key concepts for bioreactor fabrication were inexpensive costs yet use of simple and 
reproducible techniques; which included casting and curing, outsourcing steel fabrication 
and assembly by hand with protocols discussed in the following sections. 
2.3.1. Stainless steel components for the bioreactor head 
CorelDraw X5 version 15.0.0.486 was used to accurately design steel trays, arms and bases 
for the bioreactor, intended for machining on a 1 mm thick medical grade 316 stainless steel 
A4 sized sheet which provided components for twelve bioreactors (Fig. 2-4) (Appendix – 
AutoCAD file “CAD2000_v4SS-ArmsBasesTrays.dwg”). These were cut by a local steel 
fabricator (Langfords Metal Fabricators, Queensland, Australia). The cut steel components 
were cleaned of flash, washed in warm soapy water and dried thoroughly before being used 
for casting the polydimethylsiloxane (PDMS) bioreactor head.  
 
Figure 2-4 Computer aided designs of the drip-perfusion bioreactor head components to 
be fabricated from steel 
The design schematics were transcribed into CorelDraw X5. The components were tiled to 
provide maximum number of fabricated items enough for twelve bioreactor systems. 
Measurements were taken from tubing components to be integrated. The top items represented 
the base components with holes for feeding tubes, air exchange and medium return tubes to be 
fitted, the middle items consisted of support arms serrated at the top end to provide traction 
within the casted silicone, and the bottom items included the scaffold support trays with an 
integrated web pattern allowing medium to pass through.  
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2.3.2. Moulds for the bioreactor heads  
A casting mould for the bioreactor heads were designed to be assembled from five layers of 
laser-cut 6mm polymethyl methacrylate (PMMA). These were also designed in CorelDraw X5 
version 15.0.0.486 spread over two A4 sheets (Fig. 2-5) and cut using a 2.5D Professional 60 
series laser cutter (Universal Laser Systems, Arizona, USA) (Appendix -“CAD2000_v4Acr-
MouldLayers12.dwg”, “CAD2000_v4Acr-MouldsLayers345.dwg”). The mould layers were 
assembled and aligned with Ø 6 mm threaded bolts and matching wing nuts.  The resulting 
mould was capable of casting seven bioreactor heads (Fig. 2-2 A) in one batch.  
 
Figure 2-5 Bioreactor head casting moulds in computer aided designs to be fabricated from 
polymethyl methacrylate 
Five mould layers were modelled in CorelDraw X5. Fabricated polymethyl acrylate moulds were 
designed to be aligned vertically creating the physical negative volumes for casting the bioreactor 
heads. Layers ordered left to right correspond to superior to inferior layers when vertically 
stacked. 
 
2.3.3. Bioreactor head casting 
The bioreactor head was designed to integrate the majority of the functioning aspects of the 
system. These aspects included an air trap, air exchange capability and the drip feed outlets.  
2.3.3.1. Air trap and drip feed casting 
Platinum-cured silicone tubing 2.39 mm outer diameter (O.D.) 0.79 mm internal diameter 
(I.D.) (John Morris - Cole-Parmer, Australia) was measured out to 60 cm in groups of six 
(identical tube lengths were important to ensure equal pressure drop across each tube). The 
six lengths of tubing were sealed at the same end with a silicone sealant (Selleys, Australia). 
Once the sealant cured, the tubes were inserted into a 2 mL centrifuge tube (VWR 
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International Pty. Ltd., Australia) containing 1 mL of premixed PDMS Sylgard® 184 (Dow 
Corning, Australia) mixed 10:1 with Sylgard® curing agent, according to manufacturer’s 
instructions. The cast was cured in an 80 °C oven for one to two hours. The cured cast was 
removed from the 2 mL tube and the silicone-embedded tubing bundle was cut to remove 
the sealant covered ends.   
2.3.3.2. Bioreactor head plug casting 
The loose ends of the connected six silicone tubing were threaded through the stainless steel 
base component (Fig. 2-6) and then placed into the assembled five layer PMMA mould. Two 
additional tubes were placed into the base component accommodating medium return 
route and air exchange. The tubing-base joints were sealed with a small volume of premixed 
PDMS Sylgard® 184 and placed in an 80 °C oven for one to two hours of curing. The cast was 
then filled with premixed PDMS and placed back into the 80 °C oven overnight. Once the 
cast was cured the mould was disassembled layer by layer. The cast bioreactor head was 
then cleaned of silicone flash before bioreactor assembly. 
 
 
Figure 2-6 Schematic of steel base with tube integration and mould placement 
(A) The steel base component indicating locations for tube placement. (B) Semi-transparent 
representation of the steel base component shown. Six silicone feeding tubes, air exchange tube 
for pressure equilibrium and medium return tubes have been threaded through the steel base. 
Subsequently, the steel component is placed on top of inferior mould layer indicated in (C) and 
cast is filled with polydimethylsiloxane. 
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2.4. Bioreactor assembly and preparation 
The bioreactor heads were autoclaved then moved to a class II biological safety cabinet to 
connect feeding and output tubing. Lengths of these tubing were measured out to cover the 
distance from the incubator to the peristaltic pump (John Morris Scientific Pty Ltd, NSW 
Australia) and back into the incubator.  
Polypropylene hose barb fittings and luer fittings, and polycarbonate check valves (John 
Morris Scientific Pty Ltd, NSW, Australia) were used to connect the tubing together. These 
components were sterilised within the safety cabinet in 0.1% peracetic acid in Milli-Q water 
pH 7.5 for 1 hour and flushed with phosphate buffered saline (PBS) before integrating with 
the tubing from the bioreactor head. An autoclaved 0.22 µm air filter (Merck Millipore, 
Australia) was inserted into the air exchange/pressure equilibrium tube completing the 
assembly of the bioreactor head.  
A pre-sterilised fabricated scaffold (Section 2.5) was placed onto the suspension tray of the 
bioreactor head which was inserted into a Corning® 500 mL centrifuge tube (Sigma-Aldrich, 
Australia) and then the completed bioreactor system was moved into an incubator.  
Drip-perfusion bioreactors were fabricated with a total of n = 6 individual systems, providing 
six time points of 3D cell culture analysis for a set culture duration. The six systems were 
trialled using 50 mL of Milli-Q water over three days to evaluate the integrity of fluid handling 
within the bioreactor head and circulation loops. The drip feed outlets were monitored twice 
daily, 6 hours apart to evaluate the dripping consistency of each system.  
 
2.5. Scaffold fabrication 
Culturing within the bioreactor required a physical support to assist 3D proliferation of cells. 
The scaffold architecture was an important aspect for directing medium that was perfusing 
through the 3D structure when integrated into the drip-perfusion bioreactor system. This 
medium guidance provided routes of nutrient and gas delivery and removal for the cells 
cultured within the scaffold. Two techniques were used to fabricate two different 
architectures of scaffolds.  
2.5.1. Fabrication of scaffolds via thermally induced phase separation  
Poly-DL-lactide (PDLLA) (Purasorb MSDS, Australia) scaffolds were fabricated using thermally 
induced phase separation (TIPS) (Cao, et al., 2004). Four percent PDLLA in ethylene 
carbonate (EC) (SigmaAldrich, Australia) was stirred at 65 °C until dissolved into a 
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homogenous solution. The solution was aspirated into 30 mL syringes assisted by 5 cm length 
of silicone tubing (John Morris - Cole-Parmer, Australia) and the syringe left to sit upright at 
room temperature with the tubing curled upright beside it. The solution cooled to room 
temperature within 1.5 hours and a fleck of ethylene carbonate crystal on a syringe tip was 
inserted into the solution in the tubing to induce crystallisation. This reaction continued into 
the syringe chamber, and the mould was left overnight to ensure complete crystallisation. 
The crystallised solution was removed from the syringe by cooling at -20 °C for 10 minutes 
before using a Dremel rotary tool to gently score open the syringe chamber. The crystallised 
solid was immediately suspended in a loose-weave mesh bag at the top of a container 
containing 2 L of an ice/distilled water slurry and left in a cold room at 4 °C to leach away the 
EC. The distilled water was changed every 12 hours over a period of 2.5 days. The PDLLA 
cylinder was then removed from the distilled water and sectioned perpendicular to the axis 
creating scaffolds used for culturing. 
2.5.1.1. Scaffold sectioning jig 
A cutting jig was required to section TIPS scaffolds with repeatability. The jig was designed 
in CorelDraw X5 version 15.0.0.486 and fabricated from PMMA using a 2.5D Professional 60 
series laser cutter (Universal Laser Systems, Arizona, USA). The sections were assembled and 
fastened with generic acrylic cement. (Appendix - CorelDraw files - 
“ScaffoldJigHandleV14.cdr”, “ScaffoldJigV14.cdr”). The sectioning jig was tested using 
fabricated TIPS scaffolds (Section 2.5.1) to validate similar volumes of wedge samples and 
cross sections were cut. Three scaffold wedges per scaffold were cut and weighed (n = 9 
samples, conducted in triplicates). Statistics were performed on these wedge samples with 
a one way analysis of variance (ANOVA) to determine if a difference amongst the masses 
existed.  
2.5.2. Scaffolds fabricated by fused deposition modelling 
The second scaffold design consisted of polylactide (PLA) (MakerBot, New York, USA), was 
designed using G-code and printed by melt extrusion (Domingos, et al., 2009) using a 
MakerBot 3D printer (MakerBot, New York, USA). These fused deposition modelled (FDM) 
scaffolds were fabricated with dimensions of 3 mm height and 24 mm in diameter. The 
scaffold pores were 2 mm sided squares formed by the grid pattern (Fig. 2-7). These FDM 
scaffold discs were stacked into four layers with an approximate 60° offset angle to improve 
cell seeding as detailed by (Bartnikowski, et al., 2014). The discs were immobilised with metal 
pins for alignment and placed into the bioreactor chambers for cell culturing. 
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Figure 2-7 Three dimensionally printed polylactic acid scaffolds stacked four layers with 
pattern offset 
An initial polylactic acid disc was laid down (A) and with each additional 3 mm high disc the grid 
pattern was offset by 60 ° to the disc pattern below (B) and (C). The fourth disc (D) returned the 
grid to the original orientation. Overall the overlaid grid patterns were expected to increase the 
catchment of perfused cells through fibre network.  
 
 
2.6. Cell culture and expansion 
NIH-CCL92 mouse fibroblasts (3T3s) were selected as a standard fibroblast model for 
validating the drip-perfusion bioreactor due to their production of ECM proteins for cell 
attachment to the scaffold, swift proliferation rate and ease of maintenance. The 
maintenance and culturing techniques are explained in the following sections. 
2.6.1. Two dimensional cell culturing 
3T3s were cultured in T-175 cell culture flasks (Thermo Fisher Scientific Australia Pty Ltd, 
Australia) using DMEM containing 5% foetal calf serum (FCS) and 1% penicillin and 
streptomycin; henceforth referred to as DMEM-FCS. At 90% confluency the cells were 
passaged with 0.05% Trypsin-Ethylenediaminetetraacetic acid (EDTA), centrifuged at 100 g 
for 5 minutes and seeded 1:10 in fresh DMEM-FCS. 3T3s were maintained at 37°C, 5% CO2 
and medium was changed every 2 days. Passage numbers ranged from 38 to 42.  
2.6.2. Three dimensional cell culture in bioreactors 
To culture the 3T3 fibroblasts in 3D, cells were seeded onto either the PDLLA TIPS scaffold 
or the FDM PLA scaffold. Both scaffold types were seeded using the following parameters.  
2.6.2.1. Scaffold preparation 
A PDLLA TIPS scaffold or PLA FDM disc stack was placed onto a bioreactor tray and the 
bioreactor systems were assembled. The entire bioreactor system barring the peristaltic 
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pump was moved into the incubator set at 37 °C and 5% CO2. The external tubing was 
threaded through the rear porthole of the incubator. The bioreactor system and the 
scaffolds were sterilised by recirculating 50 mL of 0.1% peracetic acid in Milli-Q water 
adjusted to pH 7.5, for an hour. Peracetic acid was removed by first exchanging twice with 
50 of mL PBS, followed by 50 mL DMEM-FCS. This was perfused through the system 
overnight to detoxify any residual peracetic acid and prime the scaffolds for cell seeding. The 
following day the DMEM-FCS was removed and the scaffolds were dynamically seeded with 
fibroblasts. 
2.6.2.2. Dynamic scaffold seeding and 3D cell culture 
Dynamic seeding commenced with five million 3T3s suspended in 50 mL of DMEM-FCS then 
injected into the bioreactor circulation loop via the feeding tube line with the peristaltic 
pump set to a flow rate of 3 mL/min. The medium containing cells was recirculated at the 
same rate for three hours, dynamically delivering the cells to the scaffold within the chamber. 
Subsequently, 50 mL of medium was added into each chamber and the flow rate was 
reduced to 1 mL/min for cell culturing. This process was repeated in all six chambers. 
The first change of medium involved a 50 % exchange with fresh DMEM-FCS. At the second 
medium change the majority of the reservoir contents were replaced with fresh 50 mL 
DMEM-FCS. A small volume of medium remained in the reservoir due to the bioreactor 
design, wherein the medium-return tubing sat above the reservoir floor. Thereafter, medium 
was changed every two to three days. Cultured TIPS scaffolds were harvested at time points 
3 hours, 1 day, 2, 3, 5, and 7 days, while the FDM scaffolds were harvested at time points of 
3 hours, 1 day, 7, 14, 21, and 28 days; this was due to differences in scaffold pore sizes and 
expected pore occlusion rates caused by 3D cell culture growth. Reservoir medium was 
assayed for cell numbers at time points 3 hours, 1 day and 2 days. Harvested scaffolds were 
then prepared for cell viability, cell staining and DNA quantification assays. 
 
 
2.7. Cell viability of three dimensionally cultured cells 
Three dimensional cell cultures were harvested at set time points and cell viability was 
validated with an MTT assay (Sigma-Aldrich, Australia). With assistance of the scaffold 
sectioning jig, a 1 mm thick vertical cross section was cut from the centre of each TIPS 
scaffold and placed into a six well Nunc plate for staining (Thermo Fisher Scientific Australia 
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Pty Ltd, Australia). These scaffold pieces were incubated in 0.5 mg/mL MTT at 37 °C, 5% CO2 
for 1.5 hours. Slices were rinsed with PBS and fixed in 4% paraformaldehyde (PFA) before 
imaging.  
For the FDM PLA scaffold the discs 1 and 3, superior to inferior, were harvested from the 
four layer disc stack and assessed for cell viability. The discs were submerged in 2 mL of 0.5 
mg/mL of MTT for 1.5 hours at 37 °C, 5% CO2. These stained discs were then fixed in 4% PFA 
prior to macroscopically visualising locations of cellular activity which would indicate viable 
cells. 
 
2.8. Cell number calculations and DNA quantification 
To investigate cell numbers within the scaffolds, two protocols were used. The first method 
involved a cell count of the reservoir medium and the second method DNA was isolated from 
3D cultures and measured using spectrophotometry. The theoretical weight of DNA in a 
single 3T3 cell was correlated to the quantity of DNA in the scaffold. This quantity was used 
to calculate the total number of cells in the cultured scaffold, while the cell count assay of 
the chamber medium was used to assess seeding efficiency and identify unattached cell 
migration in the medium.  
2.8.1. Counting unattached cells within the chamber medium of the bioreactor 
A bioreactor cultured scaffold was harvested at time points 3 hours and 1 day and the 100 
mL of medium from these bioreactor chambers were used for cell counting. The remaining 
four bioreactor chambers involved a 50% medium exchange and these 50 mL samples of 
media were used in calculating cell numbers. The samples of medium (n = 3, performed in 
triplicates) were centrifuged at 100 g and resuspended in 5 mL of DMEM-FCS. A 100 μL 
aliquot was taken from the fresh cell suspension diluted with 100 μL of Trypan Blue stock 
solution (Life Technologies, Australia). The heterogeneous solution was then pipetted into a 
haemocytometer and cell counting with subsequent cell number calculations per chamber 
were performed. The samples for each scaffold experiment, TIPS and FDM, correlated to the 
six chambers.  
2.8.2. DNA isolation 
DNA was isolated from the cultured scaffolds using a modification of the hot sodium 
hydroxide and tris (HotSHOT) method (Truett, et al., 2000), replacing the 10 mM NaOH with 
1 M NH4OH.  Three alternating wedge sections (Fig. 2-8) were harvested from the full 5.4 mL 
TIPS cultured scaffolds with the aid of the scaffold sectioning jig (Section 2.5.1.1). Each 
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wedge was minced into approximately 1 mm3 pieces and incubated in 1 mL of 1 M NH4OH, 
0.2 mM EDTA at 98 °C for 1 hour. The temperature was reduced to 60 °C for 10 minutes 
allowing DNA to anneal. The contents were cooled to room temperature then 200 µL of 
chloroform was added. The solution was repeatedly inverted mixing the contents then 
rested for 10 minutes allowing phase separation to occur. A 200 µL aliquot of the aqueous 
phase was taken and dried using a concentrating vacuum system (Concentrator plus; 
Eppendorf, Germany) for 4 hours. The resulting DNA pellet was resuspended in 100 µL of 10 
mM tris-HCl buffer pH 8.0 for downstream processing.  
This protocol was used on the cultured TIIPS scaffolds at each harvest point 3 hours, 1 day, 
2, 3, 5 and 7 days; giving n = 6 samples with 3 technical replicates of scaffold wedges. 
 
Figure 2-8 Schematic of steps to select representative samples of cultured TIPS scaffolds 
(A) Cultured TIPS scaffolds were harvested at designated time points, (B) then sectioned into 
sixths using the sectioning jig (Section 2.5.1.1). (C) Three alternating wedges were taken and used 
in the NH4OH modified HotSHOT protocol.  
 
 
 
2.8.3. PicoGreen® assay and cell calculations 
The double stranded DNA (dsDNA) isolated from the scaffold cultures were serially diluted 
from 1:100 to over 1:100000 and then stained with Quant-iT™ PicoGreen® (Life Technologies, 
Australia), according to the manufacturer’s protocol. The incorporated dye was measured 
with a POLARStar OPTIMA plate reader (BMG Labtech Pty. Ltd., Germany). The dye was 
excited at 480 nm and measured at 520 nm. An optimised 1:10000 dilution was used for the 
harvested TIPS samples to acquire the fluorescence results; these were correlated with a 
standard curve using λ DNA (Promega, NSW, Australia) prepared according to the 
manufacturer’s instructions. Fluorescence results from the cultured TIPS scaffold samples 
were used to calculate the number of cells in each scaffold assuming a standard value of 6.1 
pg DNA per cell ((Kimura & Yanagimachi, 1995; Laird, 1971)). A logistic function was fitted to 
the calculated cell numbers to describe an ideal cell population growth within the TIPS 
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scaffolds (Pearl & Reed, 1920). Sample sizes for this protocol were derived from the DNA 
isolation mentioned in the previous section; n = 6 samples were harvested at designated 
time points with 3 technical replicates.  
2.8.4. NH4OH modified HotSHOT protocol efficacy  
To ascertain the accuracy of DNA isolated from the 3T3s cultured in TIPS scaffold murine 
3T3s were cultured in 2D (Section 2.6.1) and the DNA was extracted from 0.1 x106, 0.5 x106, 
1 x106, 5 x106 and 10 x106 cells to generate the standards. To assess the effect of scaffold 
material on isolation efficiency, cells were mixed with a scaffold wedge (Fig. 2-8) which was 
minced into approximately 1 mm3 pieces. The modified HotSHOT protocol outlined above 
was used and the DNA content was extracted and assayed with Quant-iT™ PicoGreen® 
fluorescent dye. The fluorescence was measured and used for statistics. 
Five mentioned cell samples and a control (0 cells) were used in the two conditions of cells 
with and without scaffolds; n = 6, conducted in triplicates.  
2.8.5. Statistics  
Cell counting was performed on the medium collected from the first harvests at 3 hours and 
1 day and the first medium exchange for the remaining chambers at day 2. Cell count results 
for both TIPS and FDM cultured scaffolds were conducted with samples (n = 3) and each 
sample performed in triplicates. A one way ANOVA (P = 0.05) was applied to the data sets to 
assess differences amongst the samples of unattached cell numbers at the first media 
change, from each bioreactor chamber with an inoculation of 5 x106 fibroblasts for TIPS 
scaffolds. This process was repeated with the FDM scaffolds. A post-hoc analysis was 
performed using a student’s t-test to identify where the significant difference existed 
amongst possible combination pairs and a Bonferroni correction was applied to 
accommodate false positives (Bonferroni, 1936; Weisstein, 2014).   
DNA isolation experiments were performed with 3 technical replicates, with n = 6 samples 
where cell numbers were 0, 0.1 x106, 0.5 x106, 1 x106, 5 x106, and 10 x106 cells for two 
conditions of cells mixed with scaffolds and cells only. Data sets were presented in graphs as 
mean ± standard error of the mean. Unpaired student’s t-test was performed on cell sample 
sizes with P < 0.05. 
The two data sets were fitted with logarithmic curves and the ratio between the two 
equations was identified as the correction ratio. The initial cell numbers calculated from DNA 
isolation were adjusted for basal scaffold fluorescence levels before applying the correction 
ratio. 
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2.9. Fluorescent staining of three dimensionally cultured cells  
Cell-scaffold localisation, 3D cell-cell structures and scaffold-cell interactions were visualised 
by staining the cells using actin- and nuclei-specific fluorescent dyes. FDM PLA discs 2 and 4 
were harvested from the four layer stacks and fixed in 4% paraformaldehyde for 30 minutes 
at 4 °C. The discs were incubated in 0.1% Triton X-100 (Sigma-Adrich, Australia) for 5 minutes 
on an orbital shaker, rinsed with PBS twice, and incubated for 1 hour with 1% bovine serum 
albumin (BSA) diluted in PBS The discs were stained for F-actin by incubating in 1:50 stock 
solution of phalloidin conjugated with fluorescein isothiocyanate (Life Technologies, 
Australia) in 1% BSA-PBS for 30 minutes before rinsing twice with PBS. To counterstain nuclei, 
cells were incubated for 5 minutes with 300 nM DAPI (4',6-Diamidino-2-Phenylindole, 
Dihydrochloride) (Life Technologies, Australia) and washed twice in PBS.  The sections were 
stored in PBS until further use. On the day of microscopy the PBS was exchanged with 
mounting medium containing 1% 300 nM DAPI and 9% glycerol diluted in PBS. These 
fluorescently stained discs were visualised with confocal microscopy using the Leica SP5 
confocal microscope (Leica Microsystems Pty Ltd, Australia). 
  
  
38  Chapter 2: Materials and methods  
 
 
 
 
 
 
 
 
Chapter 3: Bioreactor design and fabrications  39 
 
 
 
 
 
 
 
Chapter 3 
 
Bioreactor design and fabrication 
  
  
40  Chapter 3: Bioreactor design and fabrication  
3.0 Bioreactor design and fabrication 
3.1. Introduction 
This chapter discusses the results of the first two aims of the project: the design of a drip-
perfusion bioreactor and the fabrication of the bioreactor design.  
A bioreactor design that is inexpensive to fabricate, scalable, flexible, and can be translated 
to clinical purposes will provide more potential options for biomedical researchers 
interested in tissue regeneration and protein production.   
The research in tissue engineering and protein production uses bioreactors to a large degree 
and have produced successful results (Bartnikowski, et al., 2014; De Jesus & Wurm, 2011; 
Ishikawa, et al., 2011; Jain, et al., 2011; Rausch, et al., 2013; Zhang, et al., 2010). There are 
numerous commercially available designs. These systems commonly contain integrated 
circuitry for monitoring, maintaining and operating, which require specialised knowledge on 
top of expensive product and training costs (Eibl, et al., 2010). One bioreactor example 
designed by Caicedo-Carvajal & Liu (2012) and offered by Sigma-Aldrich, retails at $26,100 
for a 6 chamber 3D cell culturing, perfusion design (Sigma-Aldrich Co. LLC., 2014). 
Alternatives  to these complex systems are bioreactors that require particular knowledge 
and experience for upkeep and operation due to their highly customised designs (Powers, et 
al., 2002).  
A potential solution is to establish a drip-perfusion bioreactor system designed to be 
maintained and operated simply, and user-friendly. Additionally the fabrication processes 
involved would be non-complicated techniques and source a majority of components from 
laboratory available products. This chapter provides the details of the design and fabrication 
results of the drip-perfusion bioreactor.  
 
3.2. Experimental Procedures 
The details of these methods have been provided in Chapter 2. The following outlines the 
overall procedure required to design and fabricate a drip-perfusion bioreactor system.  
The bioreactor system was conceptualised with schematics (Fig. 2-2 and 2-3), then 
deconstructed and translated to computer aided design (CAD) files (Fig. 2-4). Acrylic parts 
were fabricated by in-house 2.5D laser cutting while stainless steel parts were outsourced 
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to a commercial laser cutter (details in Sections 2.3.1 and 2.3.2). The fabricated medical 
grade steel components and PMMA moulds were cleaned before use.  
Six platinum-cured silicone tubing were bound together, cast in premixed PDMS and 
sectioned. The loose ends of the tubing were integrated into a steel base component, which 
in turn was placed into the PMMA bioreactor casting mould. Additional tubing and 
components were integrated into the base component before the mould was cast with 
freshly mixed PDMS/curing agent (methods in Sections 2.3.3.1 and 2.3.3.2). After curing the 
cast bioreactor head was autoclaved and connected with peracetic acid sterilised 
polypropylene/polycarbonate fittings under sterile conditions in a biological safety cabinet 
(methods in Section 2.4).  
Polymeric scaffolding was fabricated for supporting 3D cell culturing in the drip-perfusion 
bioreactor. Scaffolds were fabricated by thermally induced phase separation of PDLLA from 
ethylene carbonate (EC). These scaffolds were 12 mm in height, 24 mm in diameter and 96% 
porosity (methods in Section 2.5.1). A second scaffold architecture was fabricated using 
fused deposition modelling of PLA. The disc dimensions were 4 mm in height, 24 mm in 
diameter, 80% porosity and stacked four layers with an approximate 60° offset angle 
between discs (Fig. 2-7)(methods in Section 2.5.2). 
 
3.3. Results 
3.3.1. Bioreactor design  
The drip-perfusion bioreactor design evolved through several versions beginning with the 
single chambered bioreactor system progressing to the latest design. The current design for 
the drip-perfusion system accounted for limitations in previous versions; which included 
scaffold size, physical bioreactor volume and housing, and uneven flow in drip feeding 
(Section 3.5 Discussion). The schematics were illustrated (Fig. 2-2 and 2-3) and each section 
of the system was analysed for desired functioning yet refined for simplicity of operation 
(Fig. 3-1 A).  
The key controlling components of the system were the 3-way valve and the pumps. The 
peristaltic pump was integrated into the design providing medium uptake and circulation 
throughout the system. The pump drew medium in and along the feeding line, redirected by 
the 3-way valve into the medium loop and delivered to the top of the bioreactor head (Fig. 
3-1 B) where it was drip-perfused onto the scaffold below (Fig. 3-2).  
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Figure 3-1 Design schematics of full perfusion system for one bioreactor chamber   
(A) The full bioreactor system including incubator, peristaltic pump, and overview of the 
medium circulation loop. The design involved the bioreactor system being placed inside an 
incubator (dotted line) that supplied 37 °C and 5% CO2 to the bioreactor system. Gas permeable 
silicone tubing was incorporated into the circulation loop design. The 3-way stopcock was 
designed as a control valve directing medium route in, out or around the system. The current 
setting for the 3-way stopcock recirculate medium when maintained a cell culture. (B) The design 
of the medium uptake route for the drip-perfusion system. Medium uptake was designed to 
draw via the feeding line driven by peristaltic pump and circulated to the bioreactor head. The 
3-way stopcock routed medium away from the bioreactor reservoir. The waste line was designed 
to maintain higher pressure during medium uptake directing medium to the peristaltic pump and 
bioreactor head. (C) The design of the medium removal route from the drip-perfusion system. 
The design allowed media exchanges without opening the chamber. A Jackson-Pratt drain (a 
manual hand pump) was placed after a check valve. The 3-way valve would be adjusted to route 
medium from the reservoir to the hand pump. The manual device would be depressed and 
suction used to draw the medium into its bulb. The device would draw medium from the 
chamber when decompressing and when depressed again waste medium would be expelled 
from the system. This design also allowed circulation and drip-perfusion to continue while waste 
media was removed, however the level of reservoir medium needed to stay above the bottom 
of the outlet tube else the system would uptake air into the circulation.  
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The route for medium removal from the bioreactor chamber was not connected to the 
peristaltic pump and hence required a manual hand pump for its disposal (Fig. 3-1 C). The 
medium flow was regulated by the 3-way valve and directed to flow through the hand pump 
and out to the waste tube.  
The bioreactor head was designed for nutrient delivery and gas exchange which relied on 
medium flow. The design of the medium delivery was to distribute drips evenly onto the cell-
containing scaffold area below. Five drip feed tubes spaced uniformly around a central drip 
feed tube was incorporated into the design. Furthermore, an air trap was placed in the 
circulation loop before the bioreactor head to prevent gas bubbles accumulating within the 
six dripper feed tubes (Fig. 3-2).   
The polymer scaffold was placed above the medium on a tray suspended by stainless steel 
arms attached to the base of the bioreactor head (Fig. 3-2). This placement allowed fresh 
medium to drip onto the scaffold’s superior surface and gravitationally perfuse through the 
pores to the inferior scaffold regions. Excess medium collected in the reservoir and was 
circulated by the peristaltic pump. The tapered bottom of the 500 mL centrifuge tube (Fig. 
3-2) used for the reservoir was utilized in the bioreactor design for dynamic seeding. The 
chamber’s tapered design in combination with an off-centred medium return tube allowed 
for the majority of the medium to be cycled through the system while any excess unattached 
cells or cell debris settled to the conical point of the reservoir medium remaining un-
circulated (Fig. 3-2). Additionally an air exchange tube and a filter were incorporated into 
the bioreactor head to ensure pressure equilibrium with the outside environment. 
3.3.2. Component selection 
The majority of the bioreactor components were inexpensive and readily available from 
laboratory catalogue stock. Where components had to be custom fabricated, material was 
chosen to be autoclavable. The designed components were fabricated by relatively 
inexpensive and readily available laser cutting.   
The majority of the bioreactor circulation loop tubing selected was platinum-cured silicone 
which was gas permeable, biocompatible, non-toxic and autoclavable. Tubing adapter 
fittings, luer fittings and luer caps made from polypropylene and check valves from 
polycarbonate were selected due to their transparency, common use with medical devices 
and ease of sterilisation (Bayer MaterialScience, 2010). The 0.22 µm filter, medical grade  
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Figure 3-2 Cross section of a bioreactor head and chamber design schematic 
(A) Cross sectioned design schematics of the drip-perfusion bioreactor depicting the details of 
the bioreactor head housed in a (B) 500 mL Corning® centrifuge tube (Sigma-Aldrich, Australia). 
The scaffold platform suspended using steel arms, was designed to hold a biomaterial scaffold 
up to 26 mm diameter for cell seeding. Medium reaching the bioreactor head drips directly onto 
the polymer scaffold. The medium then perfuses into the scaffold and excess medium collects in 
the reservoir. The reservoir medium is taken up by the medium return tube and recirculates 
through the closed loop by the peristaltic pump (not seen in this figure). A 0.22 μm air filter 
(Merck Millipore, Australia) was incorporated into the design allowing filtered gas exchange 
providing pressure equilibrium. An air trap was included in the design to accommodate excess 
gas build up in circulation, prevent gas build up in the drip tubes and limit subsequent disruption 
of medium flow. Additionally, the design allowed dynamic cell seeding where non-adhered cells 
would collect in the tapered bottom of the reservoir chamber. The medium suction force 
provided by the peristaltic pump would not be sufficient to draw cells from this tapered point 
into the medium loop. Medium containing non-adhered cells would be removed by the 
extraction force applied by the manual hand pump. Scale bar indicates 50 mm.  
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316 steel for bioreactor arms, trays and base components, and PDMS were chosen for their 
durable, non-toxic and autoclavable traits.  
The chamber of the bioreactor was a 500 mL polypropylene centrifuge tube from Corning® 
(Sigma-Aldrich, Australia). These tubes were not autoclavable but bought inexpensively in 
bulk from commercial vendors (Sigma-Aldrich, Australia).  
3.3.3. Mould design and fabrication 
A 2 mL centrifuge tube was used as a mould for casting the ends of the six dripper feeding 
tubes in PDMS (Fig.3-3). The centrifuge tube was placed in a rack allowing the casting to 
remain upright.  
A design for casting the bioreactor head was converted to CAD format and translated into 
PMMA templates (Fig. 3-4 A and B) which were used to fabricate the bioreactor heads. This 
was conducted successfully without complications (Fig. 3-4 C).  
 
Figure 3-3 Design of the casting overview for the air trap and six feeding tubes 
This casting technique was straightforward and used common laboratory items. This design 
bound six 2.39 mm outer diameter tubes within a PDMS cast. This cast section would be 
integrated into an air trap in the form of a sleeve of silicone tubing that fit tightly over the PDMS. 
The air trap was placed in the bioreactor system design to limit gas build up within the feeding 
tubes. (A) 2 mL centrifuge tube (VWR International Pty. Ltd., Australia) filled with 1 mL of 
premixed Sylgard® 184 and curing agent. (B) Six platinum-cured silicone tubing pre-sealed with 
a silicone sealant (Selleys, Australia) were aligned and inserted into the mixed PDMS. After 80 °C 
oven curing for one to two hours, the cast of tubing in polydimethylsiloxane was removed from 
the centrifuge tube and sectioned with a scalpel towards the bottom, removing the sealed 
silicone sections.  
  
46  Chapter 3: Bioreactor design and fabrication  
 
 
Figure 3-4 Design schematics of the mould for casting the bioreactor head  
(A) A cross section projection of the stacked layers of polymethyl methacrylate aligned for 
polydimethylsiloxane (PDMS) casting. The alignment of the mould templates would provide a 
mould for casting a bioreactor head that would tightly fit into the neck of a 500 mL centrifuge 
tube. (B) Cross sectioned front eleveation of the layered and aligned polymethyl methacrylate 
moulds. The steel base component of the bioreactor head was designed to rest within the casting 
hole of the fourth layer and sitting on top of the bottom layer. The steel base would be the 
reference point for the silicone dripper feed tubes, the air exchange tube and the medium return 
tubing. Tubes threaded through the steel base would be adjusted for correct protrusion distances, 
and cast into position with a small volume of PDMS. The mould would then be filled with PDMS. 
(C) The fabricated mould layers from top elevation showing the change in mould diameters 
creating the negative volume of the bioreactor head to be cast in PDMS. 
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3.4. Bioreactor fabrication 
The drip-perfusion bioreactor evolved through three versions to arrive at the current design. 
The results for each fabricated version are described below.  
In Version 1 of the drip-perfusion system the support arms consisted of metallic pins holding 
a PMMA suspension tray. Silicone tubing was integrated into the PDMS casted head with 
stainless steel component barrels. Blunt ended syringe needles were used for dripper feeds 
and required two bends to create a uniform distribution pattern (Fig. 3-5). These bends were 
noted as locations for blockages during cleaning of the bioreactor head. Additionally these 
stainless steel syringe needles were also problematic when cutting to size, which affected 
consistent distribution of dripped medium onto the scaffolds. The support tray limited the 
size of the scaffold that could be used for culturing.  
 
 
Figure 3-5 Version 1 of the drip-perfusion bioreactor including schematic of metal feeding 
drips  
The suspended support tray was fabricated from 6 mm polymethyl methacrylate (PMMA). 
Silicone tubes were connected to each of the six blunt ended syringe needles creating the drip 
feed outlets. The blunt needles were bent twice to create a dispersion pattern above the tray. 
The necks of the blunt needles were retained by a metal tube functioning as a collar.  
 
  
48  Chapter 3: Bioreactor design and fabrication  
Version 2 of the bioreactor was fabricated from 6 mm thick PMMA (Fig. 3-6) which replaced 
the metallic pin supports of Version 1. Additionally, the blunt ended syringe needles were 
replaced with silicone tubing removing the difficulty with shaping the metallic tubes and 
problems with uniform drip dispersion. However a build-up of gas within the circulation loop, 
originating from feeding medium into the bioreactor, was an intermittent problem. The 
design of the scaffold tray was increased in size and the fabricated component allowed a 
larger scaffold up to 26 mm diameter to sit on the platform. Problems were experienced 
with PDMS adhering firmly to PMMA (Fig. 3-6). The PMMA required cleaning and 
sterilisation with 70% ethanol by hand after each run due to the inability to autoclave PMMA. 
In some cases the PDMS heads detached from PMMA components causing sterilisation 
problems with difficulty cleaning these opened seams. Furthermore to prevent the gas build 
up in the dripper tubes an air trap was integrated into the design to provide consistent 
medium distribution.    
 
Figure 3-6 Version 2 of the bioreactor head integrating important components media 
return tube, suspension tray and filter capped tube 
The Version 2 design used sturdy polymethyl methacrylate (PMMA) arms and platinum-cured 
silicone tubing for the drip feed outlets removing problems of the Version 1 metallic drip feed 
outlets. The seam between the PMMA base component and the cast polydimethylsiloxane 
(PDMS) head was a point of tearing on multiple units (indicated by arrow). The non-adherence 
of PDMS to PMMA exposed the seams between the gas permeable silicone tubing and respective 
holes in the PMMA base component. This seam collected condensation when this version 2 
bioreactor functioned within the incubator. Scale bar indicates 20 mm. 
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Components of the Version 3 bioreactor were fabricated from medical grade stainless steel. 
There were no issues with the PDMS adhering to the stainless steel base component. 
Additionally, the medical grade stainless steel was autoclavable removing problems with 
reuse and sterilisation. The feeding dripper tubes remained as transparent platinum-cured 
silicone tubing due to the success seen in the previous version (Fig. 3-7).  
 
 
Figure 3-7  The current version of the drip-perfusion bioreactor, Version 3 
This bioreactor version used medical grade 316 stainless steel components. The platinum-cured 
silicon tubing was retained in this design for the visibility into the tubes and of any potential 
blockages. The silicone tubing was inserted into the stainless steel base component, then placed 
within the casting mould and PDMS was poured in to cast the bioreactor head. Scale bar indicates 
20 mm. 
 
 
The design of the dripper feeds required several rounds of optimisation due to uneven 
medium distribution which resulted from gas build up and subsequently non-functioning 
drip feed outlets. Different designs were trialled including, repositioning the reservoir above 
the bioreactor head for gravity induced dripping, horizontally coiled tubing in the bioreactor 
head with small drilled holes emulating a sprinkler system and different branching designs 
for the main line into three to six dripper tubes for feeding the cell culture. The latest design 
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and fabrication used 60 cm long tubes bundled and cast at one end which were all serviced 
by a larger sleeve tube delivering culturing medium. The length of these tubes removed an 
uneven pressure drop issue causing biased dripping from a few drip feed outlets, seen in 
Versions 1 and 2 of the drip-perfusion bioreactor systems.  
Initially, casting the bioreactor head resulted in PDMS leaking from the mould over the 48 
hours of curing. Raising the temperature of the curing process to 80 °C accelerated curing to 
reduce the curing time to 24 hours and minimised leakage. The curing of the six dripper 
feeding tubes in the 2 mL centrifuge tube was expedited by incubating at 80 °C and reducing 
the casting time to between one to two hours.  
The design was fabricated and assembled with the components listed in Table 3-1 in 
conjunction with their respective position within the bioreactor system listed in Fig. 3-8 A 
and B. Six individual drip-perfusion bioreactor systems were fabricated and tested for three 
consecutive days with Milli-Q water which resulted in consistent dripping from each feed 
outlet of each of the six bioreactor heads observed by inspection twice daily interspersed by 
6 hours. The inspections of the circulation loops of each drip-perfusion bioreactor did not 
show excess gas bubbles or signs of leakage indicating integrity for each fabricated system. 
The assembled bioreactors fabricated from design (Fig. 3-9 and 3-10) were validated with 
cells seeded onto two types of polymer scaffolds: PDLLA TIPS scaffolds and PLA FDM 
scaffolds, discussed in Chapter 4.0. 
 
 
Table 3-1 Component and pricing list for the construction of a single drip-perfusion bioreactor system  
The components were purchased from the correlating supplier listed for the fabrication of a drip-perfusion bioreactor system. The items are mentioned as per their 
location within the bioreactor system (Fig. 3-8). Supplier’s instructions were followed to cast the polydimethylsiloxane. The locations from 2e, i, j to 2d inclusive 
defined the circulatory system loop outside of the bioreactor head. The locations from 2c to 2p inclusive defined the waste removal line. The exceptions to these 
locations were 2a and 2b sites which involved the components to build the medium input line including the 3-way valve control point at 2d. Components were 
minimised when possible adhering to the simplicity and low-cost rationale. Diameters of connections between tubes, fittings and luers were of similar dimensions 
to ensure tight connections throughout the media loop. The prices listed factored the quantity and length (for tubes) of the components. The peristaltic pump used 
in this research was sourced from John-Morris, Australia but can be replaced with an economical and compact Welco WPX1–P1/8S2-B (Welco, Japan) model retailing 
for $80.00 AUD. The Welco peristaltic pump requires a power supply provided by a 5 Volt Direct Current 1000 milliAmpere Ultra-slim Switchmode Power Adaptor 
(Jaycar Electronics, Australia) retailing for $17.95 AUD. This power supply is able to power six Welco peristaltic pumps reducing the cost per unit build to $2.99 AUD. 
Additionally, a potentiometer RP3502 $2.95 AUD (Jaycar Electronics, Australia) is required to attenuate voltage to the Welco peristaltic pump in turn controlling the 
flow rate. The total cost of a single bioreactor build using the Welco pump, power adapter and potentiometer is $211.77 AUD.  
Component Location Item  (Ø listed as O.D, unless stated) Supplier Quantity/Item Cost/unit 
build ($AUD) 
1a, b, c - Bioreactor head Medical grade 316 stainless steel base, 
arms, tray  
Langfords Metal 
Fabricators, Australia 
1, 3, 1 respectively  $19.83 
1d Bioreactor head Polydimethylsiloxane Sylgard® 184 and 
curing agent 
Dow Corning, NSW, 
Australia 
40 mL of premixed 
Sylgard® 184 kit  
$7.86 
1e Bioreactor head, feeding tubes 60 cm of platinum-cured silicone (p-
cs)tubing Ø 2.39 mm 
John Morrsis-Cole 
Parmer, Australia (JM-
CP, Australia) 
6 lengths   $24.09 
1f Bioreactor head medium return tube 20 cm of p-cs tubing Ø 6.35 mm JM-CP, Australia 1 length   $2.46 
1f Bioreactor head top of medium return tube Tube -tube fitting Ø 6.35 mm to Ø 3.18 mm  JM-CP, Australia 1 $0.29 
1g Bioreactor head air filter tube 10 cm of p-cs tubing Ø 7.94 mm  JM-CP, Australia 1 length   $1.23 
1g Bioreactor head air filter placed at the end 
of the tube 
Vacuum Line Protection and 
Tank/Bioreactor Venting filter unit 0.22μm 
Merck Millipore, VIC 
Australia 
1   $9.30 
1h Sleeve and air trap for transitioning 6 
feeding lines into a single line 
8 cm of p-cs tubing Ø 7.94 mm JM-CP, Australia 1 length   $0.98 
1h Fitting connecting sleeve to circulation 
tube; medium return tube to circulation tube 
Tube -tube fitting Ø 7.94 mm to Ø 3.18 mm  JM-CP, Australia 2   $0.29 
  
  
1i Bioreactor chamber 500 mL centrifuge tube Sigma-Aldrich, Australia 1   $2.97 
2a End of waste tube Male luer Ø 3.18 mm barbed tip JM-CP, Australia 1  $0.13 
2a Cap feeding line Luer cap JM-CP, Australia 1 $0.64 
2b Medium feeding line 120 cm of p-cs tubing Ø 3.18 mm   JM-CP, Australia 1 $9.66 
2c Below stopcock  10 cm of p-cs tubing Ø 3.18 mm   JM-CP, Australia  $0.81 
2c End of tube below stopcock to feeding and 
waste tubes  
Y-adapter fitting Ø 3.18 mm barbed ends JM-CP, Australia 1   $0.58 
2d Circulation tube between return medium 
and feeding tube 
Polycarbonate 3 way stopcock JM-CP, Australia 1   $2.87 
2d Connect 2 channels of 3 way stopcock Female Luer Ø 3.18 mm barbed tip JM-CP, Australia 2   $0.26 
2d Connect 1 channel on 3 way stopcock Male Luer Ø 3.18 mm  barbed tip JM-CP, Australia 1   $0.13 
2e, i ,j - Circulation tube from head to pump 
and pump to return medium tube 
80 cm, 80 cm,  60 cm of p-cs Ø 3.18 mm  JM-CP, Australia 1 of each  $17.71 
2f and 2h Fitting to connect circulation tube to 
pump tube 
Tube -tube fitting Ø 3.18 mm  to Ø 2.38 
mm O.D 
JM-CP, Australia 2   $0.52 
2g Pump tube cut to size 20 cm Santoprene tubing Ø 2.79 mm  JM-CP, Australia 1   $2.94 
2g Fitted with pump tube  Peristaltic pump  JM-CP, Australia 1   
2k, m, o – Waste tubes 40 cm of p-cs tubing Ø 3.18 mm  each JM-CP, Australia 1x per each section $9.66 
2l Mid-Waste tube check valve JM-CP, Australia 1  $0.46 
2l Tube to 1 way valve Male luer Ø 3.18 mm barbed tip JM-CP, Australia 1  $0.13 
2l Tube from 1 way valve Female luer Ø 3.18 mm barbed tip JM-CP, Australia 1  $0.13 
2m Tube to Jackson-Pratt drain Female luer Ø 3.18 mm barbed tip JM-CP, Australia 1  $0.13 
2n Between tube 2m to 2o Jackson-Pratt Drain Medline, NSW Australia 1   $9.00 
2p End of waste tube Male luer Ø 3.18 mm barbed tip JM-CP, Australia 1  $0.13 
2p Cap waste  Luer cap JM-CP, Australia 1  $0.64 
Total build cost for 1 drip-perfusion system    $125.83 
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Figure 3-8 Numbered schematics of bioreactor components 
(A) Numbered components related to the bioreactor head and chamber  
The numbered locations on the bioreactor head and chamber organise the components 
beginning with fabricated stainless steel base, arms and tray 1a, b, c respectively. The PDMS was 
premixed for bioreactor head casting 1d as per manufacturer’s instructions. The loose ends of 
the six PDMS cast-bound tubes 1e were threaded through the base component 1a, along with 
the tubes for medium return 1f and gas exchange 1g. The PDMS was cast into the mould holding 
this threaded base component. The PDMS was cured at 80 °C and cleaned of excess PDMS flash. 
At location 1h an 8 cm length of Ø 6.35 mm O.D. platinum-cured silicone tube was placed around 
cast-end of the six PDMS bound tubes and a tube-to-tube fitting was connected to adapt tube 
diameter from Ø 7.94 mm O.D. to Ø 3.18 mm O.D. A similar adapter fitting Ø 6.35 mm O.D. to Ø 
3.18 mm O.D. was connected at 1f. A vacuum line protection filter unit 0.22um was connected 
at location 1g. This assembled bioreactor head was inserted into a 500 mL centrifuge chamber 
at 1i and work continued with constructing the remainder of the system.  
(B) Numbered components of the drip-perfusion bioreactor circulation system consisting of 
media feeding line, peristaltic pump, main circulation loop and waste media removal line. The 
schematic for constructing the medium feeding line, medium waste removal line and the 
circulation map were provided in relation to the assembled bioreactor head. The media routes 
were constructed beginning at the feeding line. A 120 cm of platinum-cured silicone tubing Ø 
3.18 mm O.D. was connected to a Ø 3.18 mm O.D. barbed end of a male luer with a matching 
luer cap 2a, the other end was connected to the Y-shaped adapter at 2c. The internal circulation 
loop was constructed from the reference point 2d 3-way stopcock which was matched with 
female and male luers for connecting to Ø 3.18 mm O.D. platinum-cured silicone tubing. Tubing 
was measured out to run between stopcock 2e to the pump 2f and 2h back into the incubator 2i. 
Also the circulation return loop 2j of the circuit of medium return to stopcock 2d. Two diameter 
adapter fittings 3.18 Ø mm O.D. to 2.39 mm O.D. Ø were connected at 2f and 2h to integrate 20 
cm Santoprene Ø 2.79 mm O.D. tubing fed through the peristaltic pump 2g. The medium waste 
removal route was constructed from 10 cm platinum-cured silicone Ø 3.18 mm O.D. tubing 
connected to the bottom luer at 2d which connected to a Y-shaped tube-to-tube adapter fitting 
Ø 3.18 mm O.D. barbed ends 2c. The Y-shaped adapter free end was connected to 40 cm of 
platinum-cured silicone tubing Ø 3.18 mm O.D. 2k, in turn connected to the Ø 3.18 mm O.D. 
barbed end of a male luer which was screwed into the back of a polycarbonate check valve 2l. 
The front of the check valve was connected to a female luer Ø 3.18 mm O.D. with barbed end 
and 40 cm of platinum-cured silicone tubing Ø 3.18 mm O.D. 2m. The end of this silicone tubing 
was connected to the Ø 3.18 mm O.D. barbed end of a female luer which was screwed into a 
Jackson-Pratt drain 2n. Platinum-cured silicone tubing Ø 3.18 mm O.D. 40 cm in length was 
connected to the drain and the end of the tubing was connected to a Ø 3.18 mm O.D barbed end 
of a male luer with a matching luer cap 2p.  
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Figure 3-9 Assembled bioreactor head and chamber 
The bioreactor head was cast in PDMS to anchor the junctions of the platinum-cured silicone 
tubing that made up the six dripper tubes, the gas exchange tube and the medium return tube. 
The six feeding tubes were bundled together which ended in an air trap (visible to the left of the 
bioreactor head).While injecting new medium into the system the air trap was inverted. This 
caused the entire silicone chamber to fill pushing medium through all six tubes for even dripping 
distribution. Once the medium was cycling through the system the air trap was set to the same 
alignment seen in the image. This created the trap for excess air circulating within the medium, 
which accumulated in this cavity to aid even distribution of medium into the six feeding tubes. 
The 500 mL centrifuge tube was semi-transparent also allowing visibility with a light source 
behind it. Scale bar indicates 40 mm  
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Figure 3-10 Simultaneous operation of bioreactors within an incubator 
(A) Six independent bioreactors were maintained on one shelf of an incubator, three systems in 
the front row and three systems behind. Medium circulation loops were aligned in parallel flow 
towards and from the peristaltic pump, driving medium in six chambers simultaneously. The 
bioreactor rack was designed to handle six bioreactors chambers and was fabricated from 
polymethyl methacrylate, cut with 2.5D laser cutting. (B) Three drip-perfusion bioreactor 
systems operated simultaneously within a Sanyo MCO-18AIC incubator (Sanyo, Japan).  
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3.4.1. Scaffold fabrication  
3.4.1.1. Fused deposition modelled polylactide scaffolds 
PLA scaffold discs were printed with a 3D printer (MakerBot, New York, USA) to dimensions 
of 3 mm height, 24mm in diameter, square pores sized 2 mm per side (Fig. 3-11). The 
porosity was calculated by the following equation: 
𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 𝑜𝑓 𝑃𝐿𝐴 𝑑𝑖𝑠𝑐 =
(𝑡ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙 𝑚𝑎𝑠𝑠 − 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝑚𝑎𝑠𝑠)
𝑡ℎ𝑒𝑜𝑟𝑒𝑡𝑖𝑐𝑎𝑙 𝑚𝑎𝑠𝑠
 ×  100 
The average weight was 451.8 mg ± 1.5 mg and the density for PLA was 1.145 g/cm3. The 
porosity was calculated at 78.2% ± 0.1%.  
 
3.4.1.2. Thermally induced phase separation poly(DL-lactide) scaffolds 
TIPS scaffolds were fabricated following existing protocols (Cao, et al., 2004). The scaffolds 
had dimensions of 24 mm in diameter and 12 mm in height. The scaffolds were fabricated 
by measuring 4% (w/v) of PLA in EC. With the EC leached following phase separation this 
would leave a PLA only scaffold. Porosity was calculated at 96.0% ± 0.1%. 
 
3.4.2. TIPS scaffold sectioning jig 
The sectioning jig was used to sample the cell cultured TIPS scaffolds in a repeatable manner. 
The jig was designed to slice two cross sections from the centre of the scaffold and six 
wedges from the remaining portions (Fig. 2-8 B).  
The sectioning jig was created by a laser cutter and assembled with general acrylic cement. 
Samples of test TIPS scaffolds were used to analyse the integrity of the device (Fig. 3-12).  
The results of the wedges for n = 9 samples (performed in triplicates) produced a mean of 
242.6 mg ± 2.5 mg. Performing a one way ANOVA resulted with an F value = 0.10 and an 
Fcritical value = 2.51 and a value P = 1.00. The statistical results of F < Fcritical accepts that the 
wedge shaped samples had similar mean masses and therefore no significant difference 
existed amongst the masses in the group.  
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Figure 3-11 Fused deposition modelled polylactide scaffold discs for cell culture 
(A) A sheet of 3D printed fused deposition modelled (FDM) polylactic acid (PLA) discs attached 
to printed raft. The discs were printed using programming language G-code. Scale bar denotes 
20 mm. (B) Four PLA discs were stacked and each disc pattern was offset by approximately 60°. 
A metal pin was used to align and anchor the four layers of discs before the second pin was 
inserted stabilising the offset layers. (C) The top view of PLA stacked and pinned discs. The offset 
angles can be seen when looking through the 4 mm2 pores of the subsequent disc layers. (D) A 
second perspective of the four PLA discs layered, offset and anchored by the two metal pins. 
The four PLA discs pinned as a stack and ready for bioreactor cell culturing.   
  
B C D 
A 
Chapter 3: Bioreactor design and fabrication  59 
 
 
 
 
Figure 3-12 Fabricated scaffold sectioning jig 
(A) The assembled scaffold sectioning jig with the cutting device. The jig was fabricated from 
four layers of laser cut 6 mm polymethyl methacrylate and assembled with general acrylic 
cement. The designed cavities were rectangular and cross shaped. Both of these cavities guided 
a matching cutting device to section the TIPS scaffolds. The cutting device contained a razor blade 
as seen in the upper section of the panel. (B) Two sections and two remaining TIPS scaffold 
portions. Two cross sections were cut from the middle of the test TIPS scaffold. (C) One 
remaining portion of the TIPS scaffold positioned for sectioning. The cross shaped cavity 
sectioned the remaining ‘halves’ of the scaffold into equal wedge sized sections. The scaffold half 
was immobilised by the semi-circle of the cross cavity and sliced with the razor embedded cutting 
device. (D) The cross sections and wedges cut by the scaffold sectioning jig. The wedges were 
indicated with black arrows and the cross section indicated with blue arrow. The remaining ‘half’ 
of the TIPS scaffold is intended for sectioning into three more wedges and one more cross section. 
Scale bars in all panels indicate 20 mm.       
3.5. Discussion 
Producing dense 3D cell cultures can be accommodated by a bioreactor system which is 
capable of providing an environment mimicking the natural conditions of the body such as 
A B 
C D 
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temperature, 3D cell-support architecture and the ability to provide nutrients and gas 
exchange encouraging cell growth.  
Current bioreactor designs can incorporate electrode probes connected to monitoring 
software and/or neural network systems integrating digital, electrical, mechanical and 
operational layers of complexity (Buczkowska, et al., 2010; Harper & Yi, 2013). Alternatively 
there are simple designs but constructed with customised components where the 
maintenance may cause difficulties (Bijonowski, et al., 2013; Dahlin, et al., 2012; Leong, et 
al., 2013; Wang, et al., 2012). Furthermore these design rationales are sufficient for research 
purposes but as discussed by dos Santos, et al. (2013) complex systems that are difficult to 
maintain and/or fabricate do not usually translate well to clinical applications. Therefore, the 
aim of this study was to design and inexpensively fabricate a simplistic but effective 
bioreactor system that was straightforward to operate and maintain, scalable in numbers 
and adaptable in function.   
Following this rationale of simplicity our bioreactor design adapted the perfusion bioreactor 
concept suffusing media through the cell culture and used the least amount of functional 
components as opposed to stirred tank, wavy-walled, rotating walls and wave bioreactors 
(Bartnikowski, et al., 2014; Bilgen, et al., 2006; Bueno, et al., 2005; Ishikawa, et al., 2011; 
Kelly Jr, et al., 2009; Kuriyama, 1998; Rausch, et al., 2013). These bioreactor designs involved 
hydrodynamic forces generated by the constantly moving components and environment 
such as the stirrer, the rotating walls, and the rocking bed which have the potential to detach 
cells adhered to a scaffold (Chen & Hu, 2006). The perfusion concept was expanded and drip 
feed outlets were adapted creating a novel drip-perfusion design where the medium was 
dripped onto the cell culture surface then perfused the medium into the culture under 
gravitational force. This drip feed design would provide a minimal but consistent rate of 
medium delivery which in turn would supply enough nutrients to the cell culture for growth.  
The drip-perfusion system was designed to circulate culture medium through gas permeable 
tubing reducing the need for specific gas exchange components. This would enrich the 
medium with oxygen and deliver it through drip feed and perfusion. In similar perfusion 
studies the designs used one or two pumps to circulate the culture medium as well as 
remove the media (Dahlin, et al., 2012; Gardel, et al., 2013; Yeatts, et al., 2013). One 
peristaltic pump was used to circulate the medium through the drip-perfusion system over 
the culture durations maintaining the concept of simplicity. However, media changes were 
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interspersed every two days and could be accommodated by a simple, inexpensive manual 
pump. 
The drip-perfusion bioreactor design evolved through several versions beginning with the 
single chambered bioreactor system (developed in-house by Cao & Croll). The first notable 
problem was the inability to produce replicates or time based experiments with the single 2 
L glass chamber design. This prototype bioreactor was encumbering and required two 
people to prepare, operate and dissemble when cleaning.  
The prototype drip-perfusion bioreactor was improved by reducing the size from the 2 L to 
250 mL chamber using inexpensive disposable centrifuge tubes. This allowed for single 
person handling when setting up, operating and cleaning the system. However, 
miniaturisation of the bioreactor required the support tray to be redesigned. This was 
addressed by recasting the bioreactor head with PDMS and integrating stainless steel pins 
as arms to hold the support tray. This casted bioreactor head limited scaffolds to 
approximately Ø 15 mm for this Version 1 of the adapted bioreactor system.   
Another issue was the drip feed outlets, which required replacing six syringe needles fed by 
six tubing which passed through the peristaltic pump to a simpler one tube per system 
approach enabling multiple individual bioreactor systems to operate simultaneously. This 
involved the single tube from the pump connecting onto the bundled ends of six syringe 
needles which were bent to pass through the casted bioreactor head (Fig. 3-5). These 
metallic drippers were problematic due to an uneven pressure drop across all outlets which 
caused non-uniform medium distribution and resulted in biased dripping through two or 
three of the six drippers. This dripper redesign was also affected by excess gas carried in the 
circulation path which accumulated before the dripper feeds.  
These previous design flaws were evaluated and amendments were made in the subsequent 
Version 2 system. The issue with the inadequate metallic pin arms was addressed with an 
upgraded replacement of PMMA base, arms, and suspension tray (Fig. 3-6).  The PMMA 
suspension arms were sturdier than the stainless steel pin arms however the cured PDMS 
did not adhere consistently to the PMMA base component. This caused sterilisation 
problems due to the PDMS-methacrylate loosening and openings occurring along the seams. 
During cell culture these openings were accessible to humid gas which required sterilisation 
with 70% ethanol diluted in distilled H2O at the end of the culturing period. It proved difficult 
to determine complete sterilisation of the bioreactor head. Autoclaving was not possible due 
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to the PMMA components. A similar issue of non-adherence of PDMS to acrylate was 
reported in literature and proposed the solution of laminating with a clear adhesive on top 
of the acrylate then spin-coating with the PDMS (Tan, et al., 2010). Although the study 
reported success with the technique the methodology for fabrication the PMMA bioreactor 
heads still required manual cleaning in preparation for reuse.  
The chamber design was increased in size to a 500 mL centrifuge tube with a wider neck to 
allow a larger bioreactor head to be cast. With an increase in bioreactor head diameter 
scaffolds could be accommodated up to 26 mm in diameter. The problematic drip feed issue 
was resolved with this design. The blunt end syringes of Version 1 were difficult to shape and 
cast into the mould with uniform results, resulting in the aforementioned uneven pressure 
problems. Thus, the need for uniform drip outlets was required and the blunt ended needles 
were replaced with platinum-cured silicone flexible tubes. This removed the need for 
shaping the tubes and additionally the tubes when threaded into the base component were 
able to retain their conformation, which was reinforced when cast in PDMS. The silicone 
tubes were also capable of maintaining a uniform dispersion pattern and consistent drip-
flow of medium through all six feed outlets during testing, of each bioreactor system. In 
addition, the tubes were semi-transparent and incidences of arrested flow could be 
identified, which was not an option with the metallic tubes of the Version 1 system. The 
placement of an air trap before the bioreactor head limited gas bubbles from circulating to 
the drip feed outlets servicing the system chamber. The bubbles entering the air trap were 
confined and removed from system circulation preventing pressure disparity occurring 
across the 60 cm length drip feed tubes, which occurred in Version 1 which contributed to 
biased drip-flow.  
The latest design, Version 3, retained the gas permeable silicone tubing but replaced the 
PMMA with medical grade stainless steel for base, arms and support tray components (Fig. 
3-7). This allowed autoclaving while guaranteeing sterility for cell culturing and retaining a 
robust structure of the bioreactor head. Additionally, PDMS adhered well to the medical 
grade stainless steel. Six individual drip-perfusion bioreactor systems were fabricated.  
The original procedure for withdrawing medium from Version 1 and 2 bioreactors used a 
combination of stopcocks and check valves connected to a syringe wrapped in a plastic bag 
providing sterility. This procedure involved difficult handling and there was a requirement 
to reconstruct this combination after each sterilisation. The integration of a Jackson-Pratt 
drain provided a controlled method with simpler handling of waste medium and streamlined 
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the operation and maintenance of the system. The Jackson-Pratt drains, at $9 per product 
were reused to a maximum of three times before failure.  
The current bioreactor design was tested and validated (methods in Section 2.6, 2.7, 2.8 and 
2.9) but improvements can be made. During operation there were coils of tubing leading to 
tangling (Fig. 3-10 A). These coils can be organised by integrating tube ties or fabricating a 
tube organiser that straightens tubing to prevent knotting and unintentional folding. This 
organiser could also be used to align multiple 3-way control valves removing the tube 
tangling issues when exchanging medium for multiple bioreactors.  
When considering the use of bioreactors in potential clinical settings for tissue engineering 
and regenerative medicine introducing a multilayered (mechanical, electrical, computer 
software integrated) complex design may not necessarily a feasible approach. As of 2013 
there were thousands to a hundred thousand patients registered on transplant waiting lists 
worldwide (Organ and Tissue Authority, 2014; Australian & New Zealand Organ Donation 
Registry, 2013; United Network for Organ Sharing, 2014). For a feasible tissue engineering 
scenario of organ regeneration, each patient would require a dedicated bioreactor system 
to culture patient compatible cells and regenerate a tissue or an organ. If the situation 
involved integrating excessive electrical components into the bioreactor system then costs 
for scaling bioreactor numbers would require additional finances for integrating the 
electronics, installing software, calibrating the software to the electronics as well as training 
personnel (Buczkowska, et al., 2010; Harper & Yi, 2013; Wang, et al., 2012). Fabricating 
complicated systems would require longer production times and high bioreactor demands 
would reiterate the waiting times of the transplant waiting list. Additionally, producing 
complex bioreactor systems could cause delay times to supplying TERM clinical practices 
with bioreactor equipment and if supplied reconfiguring the system for reuse may be time 
expensive. Alternatively, minimising fabrication, installation and handling costs would be a 
beneficial option when considering which bioreactor design and system to use. A validated, 
inexpensive, simply designed and fabricated bioreactor system with minimal digital inline 
monitoring would provide an appealing solution for mass production. This would also be 
beneficial when considering translation to clinical applications where simple bioreactor 
operating procedures would further reduce costs related to training and dedicated 
personnel.  
To conclude this chapter the latest drip-perfusion bioreactor design was scaled into six 
simultaneous operating systems, relatively inexpensively. The design integrated simple and 
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laboratory available components. Additionally, the bioreactor system was constructed using 
straightforward and reproducible techniques. The bioreactor evolved over several versions 
addressing several issues such as encumbrance, reuse sterilisation, uniform medium 
distribution by streamlining handling, upgrading to metal grade stainless steel components, 
and innovation of the media dripper feed design. Currently the drip-bioreactor is inexpensive, 
scalable, adaptable and user-friendly applicable for research orientated use. If the design 
was carried through to clinical applications it would be possible to adapt in-line systems for 
monitoring factors such as pH, oxygen levels, and carbon dioxide levels.  
 
This current chapter discussed the research findings relating to design and fabrication of a 
novel drip-perfusion bioreactor. The following chapter discusses the processes and results 
involved with validating the drip-perfusion system.  
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4.0 Bioreactor cell culture and validationIntroduction 
The bioreactor systems currently available, especially commercial products, have complex 
electronics, intricate designs, high maintenance costs, and require trained and experienced 
personnel (Buczkowska, et al., 2010; Gardel, et al., 2013; Wang, et al., 2012). These issues 
hinder research groups eager to include bioreactors in their experimental design (dos Santos, 
et al., 2013). Furthermore, novel bioreactor systems that are custom fabricated usually are 
synonymous with specific operating procedures (Gardel, et al., 2013). Other researchers 
interested in using these bioreactor technologies or converting them to clinical applications 
encounter impracticality issues due to their high cost and maintenance, and specific 
knowledge of seeding, culturing and harvesting with the bioreactor system. 
The design of the novel drip-perfusion bioreactor system attempted to address these issues 
by constructing with inexpensive components, simple fabrication techniques, 
straightforward operation and maintenance, and uncomplicated cleaning for reuse (Section 
1.5, Table 3.1, Section 2.2 and 2.3). The medium uptake, removal and circulation concepts 
of the design required testing and validation. These analyses would address the third aim of 
this research project: the validation of an economically viable, user-friendly, 3D cell culturing 
drip-perfusion bioreactor design.  
The drip perfusion bioreactor system designed in Chapter 3 was tested herein for its ability 
to maintain and promote cell culturing in a 3D biomaterial scaffold. These cultures needed 
verification of viability and verification of cell proliferation. These cultures also required 
demonstration of true three dimensional growth as opposed to 2D surface growth on the 
biomaterial scaffold. Polymeric scaffolds placed within the drip-perfusion bioreactor were 
cultured with 3T3 fibroblasts and at designated time points were harvested to investigate 
cell activity (MTT assay), cell proliferation (PicoGreen® assay using DNA isolated from the 
harvested cells) and to visually confirm three dimensional proliferation, cell-cell and cell-
scaffold interactions using fluorescence microscopy.  
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4.2. Experimental Procedures 
The details for the cell activity visualisation, cell proliferation assays and fluorescence 
microscopy used in regards to three dimensional cell cultures were outlined in Sections 2.5 
to 2.9.  
Murine 3T3 cells were cultured to 30 x106 in T-175 culture flasks under standard culturing 
conditions (methods in Section 2.6.1). The cells were harvested and 5 x106 cells were 
dynamically seeded into six TIPS polymer scaffolds, each inside a pre-assembled and pre-
sterilised drip-perfusion bioreactor (methods in Sections 2.4). These cell cultured TIPS 
scaffolds were maintained and harvested at time points over 7 and 12 day runs. The cultures 
were assayed with MTT to determine viable cells indicated by cell activity (methods in 
Section 2.7). Cell seeding efficiency was assessed by cell counts performed on medium 
removed from respective bioreactor chambers at harvest points 3 hours and 1 day. The four 
remaining chambers involved a 50% medium exchange at day 2 which was used in the cell 
counting samples (methods in Section 2.8). DNA was isolated from cultured TIPS scaffolds 
and quantified using PicoGreen® (methods in Section 2.8) to calculate the corresponding cell 
numbers at each time point. Additionally, an efficacy test was used to investigate the 
influence of poly-DL-lactide TIPS scaffolds on the DNA isolation protocol (methods in Section 
2.8).  
In the first bioreactor run, cultured TIPS scaffolds were harvested at time points 3 hours, 1 
day, 2, 3, 5, and 7 days (Table 4-1 and methods in Section 2.5 and 2.6). A second bioreactor 
run was harvested at 3 hours, 3 days, 9 days, and 12 days (Table 4-2); the differences in 
harvest times were assigned to investigate cell growth and identify an expected time point 
of pore occlusion caused by cell growth. 
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Table 4-1 Culturing schedule for 3T3s in TIPS scaffolds over a duration of 7 days 
Five million murine fibroblast cells were dynamically seeded per bioreactor chamber for six 
systems at time point t=0. At each harvest point a bioreactor was uncoupled from the peristaltic 
pump, and the scaffold was sectioned for an MTT assay, and DNA isolation. Cell count assays 
were performed on medium extracted from respective chambers at time points 3 hrs, 1 day, and 
2 days. Day 2 coinciding with medium exchange.  
 Harvest time point 
Bioreactor 0 1 2 3 4 5 6 
(n = 6) 0 hours 3 hours 1 day 2 days 3 days 5 days 7 days 
1 5 x106 Harvest           
2 5 x106   Harvest         
3 5 x106     Harvest       
4 5 x106       Harvest     
5 5 x106         Harvest   
6 5 x106           Harvest 
Cell count time point 3 hours 1 day 2 days 2 days 2 days 2 days 
Medium vol. used 100 mL      100 mL 50 mL  50 mL 50 mL 50 mL 
At t=0, 3T3s were dynamically seeded for 3 hours. Experiment was maintained for 7 days. 
 
 
Table 4-2  Culturing schedule for 3T3s in TIPS scaffolds over a duration of 12 days 
At time point 0 five million murine fibroblast cells were dynamically seeded per bioreactor for six 
drip-perfusion systems in total. Five time points were used to investigate the cell culture viability 
in TIPS scaffolds extending the previous 7 day experiment by 5 days, totalling 12 days. Harvested 
time points were assayed with MTT to indicate cell activity locations within the cultured scaffold.  
 
Harvest time point 
Bioreactor 0 1 2 3 4 5   
(n = 5) 0 hours 3 hours 1 day 3 days 9 days 12 days   
1 5 x106 Harvest           
2 5 x106   Harvest         
3 5 x106     Harvest       
4 5 x106       Harvest     
5 5 x106         Harvest   
                
At time point 0 3T3s dynamically seeded for 3 hours. Experiment maintained for 12 days 
 
 
The above procedure was repeated for FDM fabricated discs which were combined into a 
four layered stack and discs were labelled superior to inferior, 1 to 4 (fabrication methods in 
Section 2.5). The cell cultures in the FDM disc stacks were expected to remain viable for 
longer durations due to the larger 4 mm2 pores (compared to TIPS fabricated scaffolds), 
providing the cells, adhered to the polymer fibres, with increased space before pore 
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occlusion occurred due to excessive 3D cell proliferation. The FDM fibroblast cultures were 
maintained for 28 days duration in the drip-perfusion bioreactors. Cell seeding was assessed 
by performing a cell count assay on the medium in the bioreactor reservoir at time points 3 
hours, 1 day and 2 days. At designated time points of 3 hours, 1 day, 1 week, 2 weeks, 3 
weeks and 4 weeks, disc 1 and 3 were taken from the corresponding time point cultured 
stacks and assayed with MTT. Additionally, the remaining discs 2 and 4 at each time point 
were assayed with fluorescent staining for cytoskeletal component F-actin and cell nuclei 
which were visualised with fluorescent microscopy (methods in Section 2.9). The confocal 
images taken were compiled and analysed for cell-cell behaviour and cell-scaffold 
interaction.  
 
 
Table 4-3 Culturing schedule for 3T3s in FDM scaffolds over a duration of 28 days 
Murine fibroblasts were simultaneously dynamically seeded at time point 0 with five million cells 
per bioreactor, for a total of six systems. Six time points were used to investigate the cell culture 
viability in FDM scaffolds with pores fabricated at 4 mm2. Harvested time points were assayed 
with MTT and fluorescent staining. Cell count assays were applied to medium extracted from 
respective chambers and conducted at time points 3 hours, 1 day, and 2 days where the 3 hours 
and 1 day time points coincided with harvest points and day 2 coincided with the first  media 
exchange in the remaining bioreactor systems.   
 Harvest time point 
Bioreactor 0 1 2 3 4 5 6 
(n = 6) 0 hours 3 hours 1 day 1 week 2 weeks 3 weeks 4 weeks 
1 5 x106 Harvest           
2 5 x106   Harvest         
3 5 x106     Harvest       
4 5 x106       Harvest     
5 5 x106         Harvest   
6 5 x106           Harvest 
Cell count time point 3 hours 1 day 2 days 2 days 2 days 2 days 
Medium vol. used 100 mL      100 mL 50 mL  50 mL 50 mL 50 mL 
At time point 0 3T3s dynamically seeded for 3 hours in 50 mL of DMEM-FCS. The experiment 
was maintained for 28 days 
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4.3. Results 
4.3.1. Analysis of TIPS scaffolds cultured with murine fibroblasts 
4.3.1.1. Examining cell activity of 3T3 cultured scaffolds using MTT assay 
Cross sections 1 mm thick taken from the centre of the cultured TIPS scaffolds (Fig. 4-1 A) 
were assayed using 0.5 mg/mL MTT(methods in Section 2.7).  
The first five days of bioreactor cell culturing within the TIPS scaffold demonstrated a 
distribution of the MTT staining in the assayed cross sections. The MTT results intensified in 
staining as the time points progressed to five days. This suggested that cells were distributed 
and remained attached to the TIPS scaffold while proliferating within the 3D polymer 
structure (Fig. 4-1 B Run 1). Post 5 days the staining pattern changed to being non-uniformly 
distributed in an inferior lateral region of the cross section (Fig. 4-1 B Run 1). These results 
showed reduction in cell activity suggesting the cell culturing environment experienced 
problems which impinged cell proliferation after day 5. At the 7 day time point the limited 
MTT staining was shown similarly in the inferior lateral region of the cross section (Fig. 4-1 
B Run 1). This pattern of limited MTT staining was prominent with the second run at the 9 
day and 12 day harvest points again at inferior lateral locations of the cross section (Fig. 4-1 
B Run 2). In addition the most intense MTT staining was seen on day 9 and 12 cross sections 
where an approximate 1 mm thick stained line bordering the lateral edges were seen (Fig. 
4-1 B Run 2). The results for the large lateral inferior pattern changes shown in the MTT 
staining of day 5 and onwards, suggested a modification to the cell functioning indicating 
less cell activity in these regions. The intense staining on the lateral edges of the cross 
sections of day 9 and 12 indicated an increase in cell activity and suggested dense cell culture 
populated these scaffold locations.  
It was also noted that the superior surface of the TIPS scaffolds showed limited MTT staining 
in time points of both bioreactor runs (Fig. 4-1 B Run 1 and B Run 2). This limited MTT 
staining was most notable from the day 5 time point and onwards of both runs (Fig. 4-1 B). 
This suggested a possible issue with medium being dripped onto the superior surface of the 
TIPS scaffolds.  
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Figure 4-1 MTT assay performed on TIPS scaffolds cultured in two bioreactor runs 
(A) A 1 mm thick cross section was cut from the centre of the TIPS scaffold and used for the MTT 
assays. (B) The image panels indicate MTT stained cross sections of 3T3s cultured in TIPS scaffolds 
in two bioreactor runs, referred to as Run 1 and Run 2. Run 1 was cultured over 7 days with time 
points at 3 hours, 1 day, 2 days, 3 days, 5 days and 7 days. Run 2 was cultured over 12 days with 
time points at 3 hours, 3 days, 9 days and 12 days. Cross sections of the TIPS scaffolds were 
acquired using the scaffold sectioning jig. The cross sections were then stained with 0.5 mg/mL 
of MTT for 1.5 hours at 37 °C, 5% CO2. The results were shown against scale bars depicting a 
length of 10 mm.   
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4.3.1.2. Quantification of unattached cell numbers located in the chamber medium of TIPS 
scaffold culturing 
The seeding efficiency of the 7 day experiment of the TIPS scaffolds cultured with 3T3s was 
assessed by a cell count assay performed on the medium removed from the bioreactor 
chambers. The medium withdrawal time points coincided with: the end of dynamic seeding 
duration at 3 hours; day 1 harvest point; and the first media exchange at day 2. The medium 
samples were analysed in triplicates for cells amounts by diluting in Trypan Blue (Life 
Technologies, Australia) and a counting with a haemocytometer. Cell numbers were 
calculated and graphed resulting in the Fig. 4-2. 
The unattached cell numbers calculated at the 3 hour time point indicated 0.49 x106 ± 0.18 
x106 cells were present in the medium following dynamic cell seeding. The assay conducted 
at the 1 day time point resulted with calculations of 0.12 x106 ± 0.03 x106 cells within the 
chamber reservoir, and 0.60 x106 ± 0.04 x106 cells was calculated for the 2 day time point. 
These results indicated the number of cells present in the respective bioreactor chambers at 
the first point of medium extraction following dynamic seeding of 5 x106 3T3s.  
A one way ANOVA was conducted on the samples, n = 3 to assess possible variance in the 
cell numbers accumulated in the reservoir of each bioreactor after cell seeding at 3 hours, 1 
day and 2 days and the results showed a significant difference existed at P <0.05 amongst 
these data sets (F2, 6 = 10.5; P = 0.01). A post-hoc test with a Bonferroni correction factor 
identified the significant difference existed between the cells accumulated in the reservoir 
chamber at day 1 (M = 0.49 x106, SD = 0.19 x106) and day 2 (M = 0.18 x106, SD = 0.03 x106); 
conditions; t(4) = 2.78, p = 0.0002. These results suggested an unexpected result depicting 
the cell numbers counted in the reservoir medium at the 1 day time point was significantly 
less than the cell numbers counted in the reservoir medium at the day 2 time point. In 
addition, both day 1 and day 2 samples did not show a significant difference to the number 
of cells counted directly after dynamic seeding. 
4.3.1.3. Quantification of DNA in 3T3 cells isolated from TIPS scaffolds 
DNA isolations were performed on harvested scaffolds from 7 day bioreactor cultures using 
the NH4OH modified HotSHOT protocol (methods in Section 2.7.1). The DNA isolations were 
then quantified using Quant-iT™ PicoGreen® assay (methods in Section 2.7.2).  The 
measured fluorescence was used to calculate the cell numbers within the scaffold by relating 
the fluorescent results to the theoretical mass of total DNA in a 3T3 cell (6.1 pg/cell; (Laird, 
1971)). The results from the Quant-iT™ PicoGreen® and subsequent  
Chapter 4: Bioreactor cell culture and validation  75 
 
Figure 4-2 Calculated unattached cell numbers in the bioreactor reservoirs at first 
extraction of medium following dynamic seeding 
Numbers for unattached cells were calculated for designated time points coinciding with a 
harvest point 3 hours, 1 day and the first media exchange on day 2. The error bars denote 
standard deviation from respective means. A significant difference was found by applying a one 
way analysis of variance to the 3 samples F = 10.5 >> Fcritical = 5.14. A post-hoc test was conducted 
and the significance was identified between the 1 day and the 2 day sample, denoted by an 
asterisk in the graph. 
 
calculations were graphed (Fig. 4-3) for the n = 6 samples with 3 replicates per sample. The 
amount of 3T3s successfully seeded into the scaffold was calculated by the following 
equation: 
𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝑐𝑒𝑙𝑙𝑠 𝑠𝑒𝑒𝑑𝑒𝑑 =
𝑐𝑒𝑙𝑙𝑠 𝑐𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑑 𝑖𝑛 𝑠𝑐𝑎𝑓𝑓𝑜𝑙𝑑 (𝑡 = 3 ℎ𝑟𝑠)
𝑐𝑒𝑙𝑙𝑠 𝑠𝑒𝑒𝑑𝑒𝑑 𝑖𝑛𝑡𝑜 𝑏𝑖𝑜𝑟𝑒𝑎𝑐𝑡𝑜𝑟 (𝑡 = 0)
 ×  100 
 
An average of 3.7 x106 cells ± 0.7 x106 after 3 hours of dynamic seeding suggested a seeding 
success rate of 74% ± 14%. This result correlated to the cell numbers, 0.49 x106 ± 0.23 x106, 
counted in the reservoir medium after dynamic seeding (Section 4.3.1.2). At the day 5 time 
point a maximum of 43.7 x106 ± 5.4 x106 cells were calculated in the scaffold which dropped 
to 36.2 x106 ± 2.6 x106 cells on day 7. The error bars denoting standard deviation on the plot 
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indicated non-uniform variations of isolated DNA quantities for each respective sample; this 
suggested a non-uniform number of cells were harvested at each time point and may be 
correlated to the MTT data of irregular staining within the cross sections (Fig. 4-1). A logistic 
function was fitted to the calculated cell numbers (Fig. 4-3 and methods in Section 2.8.3). 
The fitted function (dotted line) described an ideal population growth with regards to the 
available space; the initial growth rate is exponential due to the availability of volume to 
populate which reaches a steady state then the growth plateaus due to the dwindling space 
in relation to the progression of population density (Pearl & Reed, 1920). The calculated 
results showed a difference to the logistic function showing day 2, 3, and 7 time points below 
the expected cell numbers; whereas time points for day 1 and 5 depicted higher cell numbers.  
Although these values were located within reason to the ideal growth curve, the individual 
cell numbers for the later time points required further investigating as larger cell numbers 
were originally anticipated.   
 
Figure 4-3 Cell numbers calculated from DNA isolated from TIPS fabricated scaffolds and 
assayed with PicoGreen® 
Six TIPS fabricated scaffolds were cultured with a starting inoculum 5 x106 3T3s per scaffold 
simultaneously in six drip-perfusion bioreactor systems. The scaffolds were harvested at 
designated time points. DNA was isolated from the scaffold section, assayed with PicoGreen® 
and the measured fluorescence used to calculate cell numbers for that specific time point. The 
error bars represent the standard deviation at each time point. A logistic function was fitted to 
the calculated numbers indicating an ideal population growth rate, shown by the dotted curve, 
to against the calculated numbers. 
0
10
20
30
40
50
60
0 2 4 6 8
C
e
ll 
n
u
m
b
er
s
(x
1
0
6
)
Duration of bioreactor culture (Days)
Chapter 4: Bioreactor cell culture and validation  77 
 
In analysing the calculated cell numbers the efficacy of the NH4OH modified HotSHOT 
protocol required consideration. The Truett, et al. (2000) NaOH protocol was modified to 
NH4OH for use with PDLLA TIPS scaffolds allowing increased alkali concentration to induce 
aminolysis of the PDLLA scaffolds while reducing pH to prevent alkaline degradation of DNA 
(Clark & Lubs, 1917). The efficacy of the modified protocol was examined by comparing the 
amount of DNA recovered from known numbers of freshly trypsinised cell samples to that 
recovered from identical numbers of cells mixed with TIPS scaffold material, n = 6 performed 
in triplicates (methods in Section 2.8.4). The average mass of the minced scaffold wedges 
was 243.1 mg ± 2.6 mg which was representative of the wedge shaped samples sectioned 
from bioreactor runs previously mentioned (Section 3.4.2). Differences in stained DNA 
fluorescence intensities were observed for cell samples tested (Fig. 4-4).  
Performing an unpaired student’s t-test on these results showed significant differences for 
all samples containing cells from 0.1 x106 to 10 x106 cells with P < 0.05. From these statistics 
the amount of DNA isolated and detected from the cells grown in scaffolds were not 
representative of the actual number of cells present in the cultured TIPS scaffold and 
suggested PDLLA scaffolds significantly affected the DNA isolation protocol. It was also 
noted that the 5 million cells mixed with scaffolds sample showed an unexpected lower 
fluorescence in comparison to neighbouring samples 1 million and 10 million cells mixed 
with scaffolds.  
Further analysis of the DNA isolation data involved plotting on a logarithmic scale to assess 
a possible relationship between the two sets of results, DNA isolated from cell only samples 
and DNA isolated from cells mixed with scaffold samples. The plot indicated that logarithmic 
equations could describe both data sets when values ranged from 0.5 x106 to 10 x106 cells, 
where equation y1 defined the trend for the cells only samples and y2 defined the trend for 
the cell mixed with scaffold samples (Fig. 4-5). The 5 x106 sample size for the cells mixed with 
scaffolds condition was ignored for the logarithmic curve to be fitted. From these equations 
a ratio of y1:y2 was used to calculate the representative cell numbers from the cell values 
gained from DNA isolation of the TIPS scaffolds cultured for 7 days in the drip-perfusion 
bioreactor. These corrected cell numbers were plotted (Fig. 4-6) with a seeding value of 4.63 
x106 ± 1.44 x106 cells, and a maximum value at the 5 day time point of 84.2 x106 ± 7.04 x106 
cells and a final 7 day cell number of 63.5 x106 ± 5.12 x106 cells. It must be mentioned that 
these corrected values were calculated with the y1:y2 ratio where the 5 x106 cells and scaffold 
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test result was observed as an outlier (Fig. 4-5) and omitted from calculation of the modified 
HotSHOT DNA isolation ratio from cells versus cells and scaffolds. 
 
 
 
 
 
Figure 4-4 PicoGreen® assayed DNA extracted, using the modified HotSHOT method, 
from cells grown in monolayer and from cells cultured three dimensionally within TIPS 
scaffolds.  
Murine 3T3s were cultured and counted into sample sizes of 0, 0.1 x106, 0.5 x106, 1 x106, 5 x106 
and 10 x106 cells. Triplicates of these cell numbers were treated with the NH4OH modified 
HotSHOT method. Another set of these triplicates were mixed with 243.1 mg ± 2.6 mg of minced 
TIPS scaffold and treated with the same NH4OH HotSHOT method. Both sets of isolated DNA 
were diluted and assayed with PicoGreen® with fluorescence excited at 480 nm and emission 
was read at 520 nm via spectrphotometry. Student’s unpaired t-test was performed for each 
sample size with * denoting significant results, P < 0.05. 
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Figure 4-5 Analysis of the DNA isolation data acquired from NH4OH modified HotSHOT 
protocol presented on a logarithmic scale 
The DNA isolation efficacy data was normalised to the 0 fluorescence values for each condition 
and the data sets were truncated within the range of 0.5x106 to 10 x106 cells. These data sets 
were translated onto a logarithmic scale and respective sets were defined by a logarithmic trend 
described by equations y1 and y2. The 5 x106 cells mixed with scaffolds sample was ignored to fit 
the y2 logarithmic curve.   
y1 = 1353.2ln(x) + 1826
y2 = 727.52ln(x) + 777.65
0
1000
2000
3000
4000
5000
6000
0.1 1 10
Fl
u
o
re
sc
e
n
ce
 (
R
FU
 -
n
o
m
ar
lis
e
d
 t
o
 0
 v
al
u
e
s 
o
f 
re
sp
e
ct
iv
e
 c
o
n
d
it
io
n
s)
Cell numbers (x106)
Cells Only
Cells+Scaffolds
  
80  Chapter 4: Bioreactor cell culture and validation 
 
 
 
Figure 4-6 Cell numbers calculated from the 7 day TIPS scaffold bioreactor culture 
corrected with a ratio of DNA isolation from cells to cells with scaffold 
Original cell numbers (calculated from DNA isolation) were corrected with the ratio of y1:y2 where 
the equations were defined by: y1 = 1353.2ln(x) + 1826; and y2 = 727.52ln(x) + 777.65. The 
correction ratio progressed from 2.1 to 1.9 as the cell numbers increased from 0.5 x106 cells to 
90 x106 cells. The corrected values indicated a new seeding value of 4.63 x106 ± 1.44 x106 cells 
and a maximum of 84.2 x106 ± 7.04 x106 cells at day 5.The error bars were denoted as the 
standard deviation scaled with the ratio of y1:y2 for each respective time point.  
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4.3.2. Analysis of FDM scaffolds cultured for 28 days with murine fibroblasts  
4.3.2.1. Quantification of unattached cell numbers in chamber medium of FDM scaffold 
cultures 
The first point of medium removal from the drip-perfusion bioreactor chambers were 
assayed by cell counting. These time points for assaying the reservoir medium of cultured 
FDM scaffolds included: post dynamic seeding at 3 hours; day 1 harvest time point; and the 
first media exchange at day 2 (n = 3 samples). The medium samples were analysed in 
triplicates for cell amounts using Trypan Blue (Life Technologies, Australia) and a 
haemocytometer, and calculated cell numbers were graphed (Fig. 4-7). 
 
Figure 4-7  Calculated numbers of unattached cells within bioreactor reservoirs at 
designated time points  
Numbers for unattached cells were calculated for designated time points coinciding with harvest 
point 3 hours, 1 day and media exchange on day 2. The error bars denote standard deviation of 
respective means. The cell count assay was performed at the first exchange of medium following 
dynamic seeding of the drip-perfusion bioreactor. No significant difference was found amongst 
the samples (n = 3) when a one way analysis of variance was performed on.  
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The calculated cell numbers indicated 2.41 x106 ± 2.55 x105 at time point 3 hours following 
dynamic cell seeding. The results at the 1 day time point indicated 2.46 x106 ± 5.21 x105 cells 
within the chamber. The four samples assayed at the 2 day time point were assayed and the 
average cell number was calculated at 2.43 x106 ± 4.74 x105. These cell count calculations 
indicated the amount of cells present in each bioreactor chamber at the first point of 
medium removal after dynamic cell seeding.  
A one way ANOVA was performed on the n = 3 samples to assess cell number differences 
amongst assayed media at the 3 hours, 1 day and 2 day time points. The results of this 
statistical test showed no significant difference existed amongst these samples (F2, 6 = 0.10, 
P = 0.91). This result suggested that the cells accumulated in the reservoir did not 
significantly differ since dynamic seeding to the 1 day and remained similar to 2 day.  
4.3.2.2. Measurement of cell activity of 3T3 cultured FDM scaffold using MTT assay 
PLA FDM discs were stacked in four layers and each FDM disc patterning was offset by 
approximately 60⁰ to the previous layer (Fig. 3-11 D), with n = 6 stacks. Each four layer stack 
was dynamically seeded with five million 3T3s each and cultured in a drip-perfusion 
bioreactor with harvest points ranging up to 28 days (methods in Section 2.6). The discs were 
labelled superior to inferior layers; discs 1 to 4 respectively (Fig. 4-8 A). At each harvest point 
discs 1 and 3 were taken from the four-layer PLA FDM cultured stack and cell viability was 
assayed using 0.5 mg/mL MTT staining (Fig. 4-8 B and methods in Section 2.7). 
Disc 1 showed limited MTT staining on scaffolds harvested after dynamic seeding at time 
points 3 hours and Day 1 (Fig. 4-8 Disc 1). By the first week MTT staining was evident in 
lateral and peripheral regions of disc 1 (Fig. 4-8 Disc 1). These respective disc regions 
displayed progressive MTT staining over the following time points 2, 3 and 4 weeks (Fig. 4-8 
B Disc 1). This progressive staining indicated increased cell activity in the discs suggesting 
cell proliferation was occurring. Additionally a lack of MTT staining was indicated in the 
central region of disc 1 across all related time points. These results suggested that this 
central region was not conducive to cell attachment and activity which may have been a 
causal effect from unevenly distributed medium flow through the scaffold architecture or 
lack of cell delivery to these regions. Disc 3 showed limited MTT staining for the 3 hour and 
day 1 time points (Fig. 4-8 B Disc 3). An increase in cell activity from weeks 1 to 3 was 
indicated at the peripheral and lateral regions of the discs and towards the central pores of 
the discs. A decrease in staining intensity was displayed at week 4 when compared to week  
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Figure 4-8 MTT assay of FDM fabricated discs cultured in the drip-perfusion bioreactor over 
4 weeks 
Four FDM PLA discs were stacked (A) at an offset of approximately 60° and cultured in the drip-
perfusion bioreactor with an initial seeding of 5 x106 3T3s. The four layered stacks were 
numbered superior disc to inferior, 1 to 4 respectively. At designated time points: 3 hours, 1 day, 
1 week, 2 weeks, 3 weeks and end point 4 weeks, discs 1 and disc 3 were taken from the 
harvested stack and assayed with MTT at 0.5 mg/mL concentration at 37 °C for 1.5 hours. (B) The 
MTT results were shown in relation to a scale bar depicting a length of 10 mm. 
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3 results (Fig. 4-8 B Disc 3) and suggested a possible reduction in cell proliferation or necrosis 
within disc 3. In comparison to the TIPS scaffolds and suggested onset of occlusion at day 5 
(Fig. 4-1 B), the FDM cultured scaffolds specifically in the cell activity of disc 3 suggested at 
least 3 weeks of capable cell culturing before the onset of occlusion.  
The MTT staining locations for disc 3 over the last three weeks of culture indicated cell 
activity in more regions than disc 1 counterparts. The increased MTT staining across these 
time points (week 2, 3, 4) suggested that cells were able to attach and proliferate readily in 
disc 3. MTT staining differences between disc 1 and disc 3 from week 1 indicated lower cell 
activity in disc 1 which required further analysis.  
4.3.2.3. Three dimensional cell structures visualised in 3T3 cultured FDM scaffolds with 
fluorescent microscopy 
Cell-to-cell and cell-to-scaffold interactions within the drip-perfusion bioreactor cultures 
were investigated. Four layer PLA FDM disc stacks were cultured with 3T3s in the bioreactors. 
The discs were labelled via positioning from superior to inferior: 1 to 4. The four discs per 
bioreactor chamber were harvested at 3 hours, 1 day, 1 week, 2, 3, and 4 week time points 
from the 5 x106 fibroblast 3D dynamic culture. Discs 2 and 4 were stained with phalloidin for 
F-actin and DAPI for nucleic acid (methods in Section 2.9). The fluorescently stained cells 
were visualised with confocal microscopy (methods in Section 2.9). Images were captured 
over a vertical depth into the discs then overlayed resulting in z-stacked images (Fig. 4-9, 4-
10 and 4-11).  
Cell to scaffold interaction was analysed by comparing the combined channels of 
fluorescently stained nuclei and F-actin against possible co-localisation of PLA fibre, 
indicated by a uniform line in the 633 nm reflection channel. Confocal microscopy results 
across the set of time points for both disc 2 and 4, showed variations in co-localisation 
patterns including instances of DAPI and F-actin staining which indicated cell culture aligning 
with PLA reflection (Fig. 4-9 B and C co-localisation of DAPI and FITC-phalloidin staining 
compared against PLA reflection values, location marked by the white arrows). In contrast 
to this observation, there were results of disc 2 and 4 of DAPI and F-actin staining that did 
not correlate to a suggested PLA fibre in the reflection channel (Fig. 4-9 C co-localisation 
indicated by the orange arrows). The variations of staining co-localisation shown in merged 
channel images of disc 2 and 4 were observed as sparse to grouped DAPI and FITC-phalloidin 
staining co-localised with indicated structures of PLA fibre at early time points 3 hours and 1 
day (Fig. 4-10 i, ii, v and viii); this suggested cell culture adherence at 
 
 
 
Figure 4-9  PLA FDM Disc 4 (A) harvested at time points (B) 1 week and (C) 2 weeks fluorescently stained and showing pseudo coloured channels DAPI, 
FITC-phalloidin, PLA fibre and merged channels.  
Fluorescently stained disc 4 from the stacks showed differences in co-localisation of captured channels as seen in images (B) and (C) and the panels within depicted 
channels where (i) nuclei were DAPI stained, (ii) F-actin was FITC-phalloidin stained,  (iii) PLA fibres were reflected via 633 nm laser light and (iv) was the merging of 
the three channels. The white arrows in images (B) and (C) indicated the locations where DAPI and/or FITC-phalloidin stains correlated with the reflected PLA fibre 
channel. The orange arrows (C) indicated the co-localisation of DAPI and FITC-phalloidin staining channels but lacked co-localisation with the PLA reflection channel. 
Scale bar indicates 100 μm.  
A B C 
iii iv 
i ii 
iii iv 
i ii 
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the end of 1 day within drip-perfusion culture. Results from week 1 to week 4 (Fig. 4-10 iii 
to vi and ix to xii) depicted an increase in fluorescent staining of DAPI and FITC-phalloidin 
throughout both discs which indicating a large increase in cell numbers during the 28 days 
of culture.  
Images of disc 2 at week 1 showed extensive fluorescent staining of nuclei and F-actin which 
co-localised to the PLA reflections, indicating dense cell culture on the surface of the FDM 
scaffold fibres (an exemplar image shown in Fig. 4-10 iii). From time points week 2 to week 
4 of disc 2, the fluorescent staining of cell components indicated continuation of these dense 
cell cultures localised to the reflection of PLA fibres; in addition, there were instances of DAPI 
and FITC-phalloidin staining that did not co-localise with polymer reflections (exemplar 
images Fig. 4-10 iv to vi). From these images it was clear that DAPI and FITC-phalloidin 
staining did not represent a cell culture that was entirely adherent to the surface of a PLA 
fibre (Fig. 4-10 iv to vi) but instead suggested the cell culture had proliferated and had begun 
bridging the distance between the PLA fibres of the 4 mm2 pores. 
The results for disc 4 for fluorescent staining showed dense DAPI and FITC-phalloidin staining 
both co-localising and not co-localising with indicated PLA structures in the 633 nm channel 
(Fig. 4-10 vii to xii). The fluorescent staining results for disc 4 indicated grouping of cells by 
the end of day 1 in the drip-perfusion culture (Fig. 4-10 viii); grouping of DAPI and FITC-
phalloidin staining was not as pronounced in the images of disc 2 at the same time point (Fig. 
4-10 ii). The disc 4 fluorescent staining results also indicated the dense bridge-like cell 
formations occurring at an earlier week 1 time point (Fig. 4-10 ix) compared to week 2 for 
disc 2 (Fig. 4-10 iv).  
These disc 2 and 4 fluorescent staining results when correlated with discs 1 and 3 MTT 
staining results indicated inferior discs 3 and 4 showed cell activity and dense cell presence 
at earlier time points than superiorly located discs 1 and 2 (Fig. 4-8).  
The z-stacked images comprised of cross sectional images 4 μm to 8 μm vertically apart, 
ranged from 350 μm to 450 μm in vertical distance. Further analysis of sets of z-stacked 
digital cross sections showed correlating DAPI and FITC fluorescence indicating numerous 
cell nuclei and F-actin dense structures (Fig. 4-11), and spanned across vertical distances 
over 250 μm. An example image was selected from week 3 culture of a central region of disc 
4 where FITC and DAPI fluorescence indicated a dense cell structure in the coronal 
 
 
 
 
Figure 4-10  Merged channels showing fluorescent staining of discs 2 and 4 harvested over the 4 week duration of 3T3 cultured FDM disc stacks, and cell 
culture proliferation between FDM disc fibres. 
Five million murine 3T3 cells were seeded per four layer disc stack and six stacks were cultured in respective bioreactor systems. Stacks were harvested at 3 hours, 
1 day, 1 week, 2 weeks, 3 weeks and 4 weeks. The second superior disc 2 (i) to (vi) and the inferior most disc 4 (vii) to (xii) from each cell cultured stack were 
harvested and assayed with FITC-phalloidin staining F-actin and nuclei counter-stained with DAPI. Confocal microscopy used gas lasers at 405 nm, 488 nm and 633 
nm to excite the DAPI and FITC and reflect PLA fibres respectively . Several images were taken over a vertical distance and then overlayed producing merged z-stack 
projections. An image was selected from central, lateral or peripheral regions to represent each disc at each time point. Scale bar indicates 100 μm.  
Disc 2 
Disc 4 
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cross section spanning 267.8 μm vertically (Fig. 4-11 D iii). In this coronal cross sectioned 
image it was suggested the PLA fibres had been cross sectioned perpendicular to their axes, 
indicated by the white image values identified in this image panel by white arrows (Fig. 4-11 
D iii). Additionally, this coronal cross section suggested the mentioned dense fluorescent 
staining formed a bridge-like structure spanning a 397.6 μm distance between the two 
proposed PLA fibres, indicating cell structure existing between vertical and horizontal 
distances.   
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Figure 4-11 Fluorescent microscopy of the central region of disc 4 at 3 weeks showing 
DAPI, FITC and PLA reflection channels; and a cross section at a depth of 35 μm 
A stack of four PLA FDM discs was cultured with 3T3s in the drip-perfusion bioreactor and 
harvested at week 3. Disc 4 was stained with DAPI and FITC-phalloidin and visualised with 
confocal microscopy over a vertical range of 357.4 μm. Results at a depth of 35 μm were 
examined in pseudo coloured DAPI (A), FITC (B) and reflection (C) channels indicating cell nuclei, 
F-actin cytoskeleton and PLA fibre respectively. Merging the three channels resulted with a digital 
projection which was cross sectioned at 35 μm (D i). (D ii) A sagittal cross-section section of the 
z-stack depicted a plane of FITC-phalloidin and DAPI staining. (D iii) The coronal cross section of 
the compiled z-stack indicated cross sections perpendicular to the PLA fibres’ axes, marked by 
the white arrows. Scale bars in images (A, B and C) indicated 100 μm.  
397.6 μm 
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4.4. Discussion 
The third aim of this research project involved validation of a novel drip-perfusion bioreactor 
by examining the produced cell cultures. Murine fibroblasts were seeded into two different 
scaffold architectures, fabricated by TIPS using PDLLA and FDM using PLA. Cell viability, cell 
numbers and 3D-formed cell structures were examined.  
The MTT staining seen in the cross sections of cultured TIPS scaffolds over 7 days of 
bioreactor culture (Fig. 4-1 B Run 1) showed an increase in staining intensity from the 3 hours 
to day 3. The staining pattern seen at the 3 hour time indicated cell activity was present after 
dynamically seeding the scaffold, and towards day 3 the MTT staining to various degrees was 
present in the cross section which indicated cell presence and activity. This staining pattern 
changed between day 5 and 7 where areas of limited staining correlated to internal inferior 
regions within the TIPS scaffolds. This characteristic staining was also seen within the TIPS 
scaffolds at day 9 and 12 of the second 12 day bioreactor experiment (Fig. 4-1 B Run 2). It 
was suggested these regions limited in MTT staining experienced increased cell proliferation 
that reached critical density. Subsequently, it was theorised that this critical density caused 
obstruction to medium flow through the pores halting cell proliferation and eventually 
causing nutrient and gas starvation in these internal inferior regions of the TIPS scaffolds. 
The problem of occlusion and possible onset of necrosis has been commonly reported in 
tissue engineering studies involving large volume scaffolds, where it has been elucidated 
that cells need to be ideally within a 200 to 400 μm proximity to vasculature to receive 
nutrients and oxygen (Auger, et al., 2013; Carmeliet & Jain, 2000; Rouwkema, et al., 2008). 
Following this thought, a scaffold fabricated with larger pores would sustain 3D cell culture 
for longer durations within the drip-perfusion bioreactor. This parameter was tested with 
PLA FDM scaffolds.  
As reported, the FDM scaffolds containing larger 4 mm2 scaffold pores demonstrated cell 
activity via MTT staining up to four weeks of FDM scaffold culture; this suggested medium 
delivery was maintained for an extended culturing duration compared to the TIPS scaffolds. 
Results from week 1 onwards of drip-perfusion culturing showed increased regions of MTT 
staining with disc 3 compared to the disc 1 counterparts (Fig. 4-8). The cell activity results 
combined with fluorescent staining suggested a situation where cells adhered to the inferior 
layers and proliferated at an earlier time point than on the superior disc layers. It was 
theorised that possible influencing factors involved the forces of the dripping medium and 
the architecture of the FDM scaffolds (Fig. 3-11).  
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The capability of denser cell culture over the 28 day duration in the FDM disc stack was 
anticipated due to increased efficiency of cell seeding following Barnikowski, et al.’s (2011) 
protocol where each disc layer was offset by 60° and the larger 4 mm2 pores, which increased 
the culturing duration until obstruction due to critical cell density. In addition the staining 
patterns with disc 1 showed a preference for regions close to the disc edge. The central 
regions of these discs showed limited staining which was also observed in the cross sections 
of the TIPS scaffolds. Both of these results correlated to the superior surfaces of the scaffolds 
positioned underneath the drip-feed tubes and suggested the medium dripping onto the 
scaffolds affected cell adherence in this region. It was reasoned the medium falling onto the 
scaffolds would have introduced cells to this region during dynamic seeding (correlating to 
Fig. 4-12 i), but the constant gravitational forces of the dripped medium onto the superior 
face of the scaffolds or disc stacks would have discouraged cells from adhering on this 
surface (Fig. 4-12 ii). This would also correlate to the limited MTT staining of the superior 
surface seen in the TIPS scaffolds (Fig. 4-1 B) and the superior surface corresponding to the 
central regions of the MTT stained FDM disc 1 (Fig. 4-12 i and ii). The literature reported that 
shear stress was capable of detaching 3T3s from culturing substrates such as cell culturing 
polyethylene terephthalate, implant alloys of pure titanium and stainless steel (Bundy, et al., 
2001) however these substrates were not representative of the DMEM-FCS primed polymer 
scaffolds used herein. The 3T3 scaffold cultures under dripping medium received an initial 
gravitational force possibly similar to shear stress which may have contributed to these 
superior central regions being limited in MTT and fluorescent staining. However it was 
suggested that this medium after striking the superior scaffold surface may have been 
distributed to adjoining pores in TIPS scaffolds. In FDM disc stacks it was suggested that the 
majority of medium had distributed to inferior disc layers during dynamic seeding cells (Fig. 
4-12 schematic).  
 
These inconsistency issues with medium distribution may be addressed with two approaches. 
The first method would involve modifying the scaffold architecture to reduce initial 
gravitational forces experienced by the superior surface of in the scaffold. Polymeric 
scaffolds can be designed to counter these forces employing computational fluid dynamic 
analysis software (Arrigoni, et al., 2012; Bartnikowski, et al., 2014). From the computational 
modelling the scaffolds can be 3D printed with inherent mitigation of external forces. The 
second approach would involve introducing a cell porous membrane to the superior surface 
of the scaffold and reducing the distance between the outlets of the dripper tubes  
  
 
   
Figure 4-12 Theorised flow path of drip-perfused medium, constructed from analysis of MTT and fluorescent staining, through FDM PLA scaffold stacks  
3D PLA printed discs were stacked four layers high, aseptically placed into the drip-perfusion bioreactor and seeded with 5 x106 3T3s. From the disc 1 and 3 MTT and 
disc 2 and 4 fluorescent staining results analysed over the 28 day cell culture the above path of flow was theorised. The superior discs were lacking or limited in MTT 
staining in central regions of the disc until week 3 time point (i) to (v). The lateral and peripheral regions of the superior discs showed progressive cell culture 
indicated by both MTT and fluorescent staining results proportionally to the succession of time points (i) to (xii). This suggested the lateral regions of these superior 
discs allowed cell adherence and cell proliferation. Regarding the inferior discs 3 and 4, both MTT staining results indicated cell culture growth from at least week 2 
onwards in both central and peripheral regions (xv) to (xviii) and fluorescent staining results indicated from day 1 onwards (xx) to (xxiv). This suggested more 
Disc 1 
Medium drip and perfusion path 
Superior disc 
Inferior disc 
2 
3 
4 
3 hrs 4 wks 1 day 1wk 3 wks 2 wks 
Disc 1 
Disc 2 
Disc 3 
Disc 4 
i ii iii iv v vi 
vii viii ix x xi xii 
xiii xiv xv xvi xvii xviii 
ixx xx xxi xxii xxiii xxiv 
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fibroblasts were repositioned by dynamic seeding to the inferior positioned discs (ixx and xx), where cells adhered and proliferated earlier than their superior 
counterparts (vii and viii) during the 28 days of cell culture.  
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and the same superior surface of the scaffold, both modifications decreasing the impact 
forces of the dripped medium. The medium would saturate the membrane and overflow 
would then perfuse into the scaffold. This approach can be accomplished by designing the 
support arms to have vertical holds for inserting the support platform at the desired height 
(schematics shown in Fig. 4-13), providing versatility for different sized scaffolds but does 
disregard the importance of scaffold architecture.  
 
 
Figure 4-13  Schematic of support arms allowing tray height to be adjusted 
Proposed support arm designs with mortise holes allowing integration with a tenon arm 
integrated into the support tray (A). The support tray’s spider web pattern could also be 
redesigned to accommodate different scaffold architectures. (B) The mortise with inserted tenon 
and the tray twisted locking into place. All three mortise and tenon interactions need to be 
inserted and locked simultaneously.  
 
 
Quantification of cell numbers was required to numerically validate cell proliferation and 
assess dynamic seeding capability. DNA was isolated from TIPS scaffolds and a subsequent 
PicoGreen® assay performed. The measured fluorescence and DNA weight of a 3T3 (6.1 pg 
(Laird, 1971)) was used to calculate cell numbers. Initial results suggested a seeding average 
of 3.7 x106 ± 0.7 x106 cells and a seeding efficiency of 74% ± 14%. This standard deviation 
error was suggested as non-uniform harvest of cell cultured scaffold. Correlating this data 
with the distribution of MTT staining (Fig. 4-1 B) suggested an uneven cell distribution within 
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the TIPS scaffolds. Although three alternating wedges were taken from the total six wedges 
available increasing the total sample size within distributed smaller wedges would provide a 
better representation of the cells within the scaffolds (Fig. 4-14).  
 
 
Figure 4-14  Schematic progression of TIPS scaffold sectioning for sampling cell distribution  
Full TIPS scaffold (A) that was sectioned into 6 wedges (B). From these 6 wedges currently 3 
alternating wedges were selected. (D) The proposed sectioning of a TIPS scaffold where 6 
alternating slices can be selected equalling the same volume as 3 alternating wedges (C), but 
with increased sampling better representing cell distribution within the scaffold.  
 
 
Investigation of the DNA isolation method was also required. The original protocol 
performed by Truett, et al. (2000) was used to isolate DNA from rat tail samples with 10 mM 
NaOH. When this protocol was adapted for DNA isolation from 3T3 cultured PDLLA TIPS 
scaffolds the results suggested partial aminolysis of the polymer. This issue was initially 
addressed by increasing the concentration of NaOH, but would subsequently increase the 
pH. To counter the expected pH rise the alkali reagent was changed to NH4OH with pH 11.6 
as opposed to 1 M NaOH, pH 14 (methods in Section 2.8). The final pH after aminolysis of 
poly(DL-lactic acid) was expected to move towards native cell conditions of pH 7.0 to 7.4 
which would limit alkaline denaturation of DNA (Ageno, et al., 1969; Clark & Lubs, 1917).  
This efficacy of the NH4OH modified HotSHOT protocol, with regards to PDLLA, was 
examined by comparing the conditions of DNA isolated from cell only samples against DNA 
isolated from cells mixed with PDLLA TIPS scaffold samples, n = 6 performed in triplicates for 
2 conditions. These results (Fig. 4-4) indicated that higher levels of DNA were isolated from 
the cell only samples compared to mixed samples. Performing student’s t-tests (P < 0.05) for 
each pair of samples suggested that PDLLA significantly affected the DNA amount isolated 
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from the cells mixed with TIPS samples. From this analysis, it was proposed that the original 
cell numbers calculated per designated harvest point were significantly underestimated.  
In addition, it was postulated that the DNA was binding to partially degraded PLA. Literature 
showed that aminolysis of biomaterials including PLA had been used to alter hydrophobicity 
of the polymeric surface encouraging cell adherence (Zhu, et al., 2013). Similarly in these 
results it was purported that the situation of DNA binding to small, surface functionalised, 
degraded PLA derivatives was probable. This could be addressed by increasing the 
concentration of NH4OH until complete aminolysis of PLA occurred thus removing the 
potential for isolated DNA to bind to these substances. From the literature a method by 
Alvarez‐Barreto, et al. (2011) used a combination of hydrolysis to degrade the scaffolds 
followed by sonication and freeze-thawing to lyse the cells within the cultured poly-L-lactic 
acid (PLLA) scaffold. The lysate was subsequently assayed with PicoGreen, however the 
scaffold sizes in this study were of 3 mm in height and 8 mm in diameter, 150 mm3 being 
considerably less in volume in cell culture than the 5400 mm3 PDLLA TIPS scaffolds used in 
this drip-perfusion bioreactor study. In addition, the FDM scaffolds were fabricated with 
solid PLA fibres would experience difficulty when attempting hydrolysis to degrade these 
thick structures, more so when encompassed in a high density cell culture. A second method 
of cell quantification involved degradation of a oesophageal smooth muscle cell cultured 
PLLA membrane scaffold by incubation in 3 mg/mL papain at 60° overnight resulting in a 
polymer-homogenate solution which was assayed with DNA binding stain Hoechst 33258 
and fluorescence spectrophotometry (Zhu & Chan-Park, 2007). The degradation of the thin 
membrane scaffold was performed overnight, although a large volume scaffold such as the 
PDLLA TIPS or PLA FDM scaffolds used herein used with this enzyme protocol may require 
optimisation. Increasing the papain enzyme concentration may assist with the degradation 
process. A third method used an MTT assay for 7×7×3.5 mm3 sized PLGA scaffolds 3T3 
cultured in a 48-well plate. The resulting formazan was colorimetrically quantified via 
spectrophotometry (Shen, et al., 2007). This protocol is reported as straightforward and 
again be applicable to small volume scaffolds. With dense cell cultures produced by the drip-
perfusion bioreactor there would be difficulty in ensuring uniform MTT infiltration as well as 
comprehensive removal of all produced formazan for assaying. Currently, the NH4OH 
modified HotSHOT method demonstrated a feasible approach yet further optimisation 
would be required to remove the need for further calculations after DNA isolation.  
These subsequent calculations were used to evaluate the efficacy of the modified HotSHOT 
method of the DNA isolation data derived from conditions of cells compared to cell mixed 
with scaffold. The data sets were normalised to their respective zero cell fluorescence values 
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and the ranges from 0.5 x106 to 10 x106 were translated onto a logarithmic scale (Fig. 4-5). 
The 5 x106 sample for cells mixed with scaffolds was ignored and both plotted data sets were 
defined by logarithmic functions y1 defining the cells only trend and y2 function defining the 
cells mixed with scaffolds trend. The ratio of y1:y2 was applied to the original results of 
calculated cell numbers from the NH4OH modified HotSHOT method, where the correction 
ratio decreased from 2.1 to 1.9 over the range of 5 x106 cells to 43 x106 cells.  
Analysis of the ratio of y1:y2 suggested that an eventual value of unity would be encountered 
as the cell numbers increased. It was proposed that a similar fluorescence value for both 
equations would be the cause of this unity ratio due to the fixed amount of PDLLA scaffold 
and the increasing numbers of cell. The samples of DNA isolated would be expected to 
contain very high concentrations and when assayed with PicoGreen would present a 
fluorescence value where saturated DNA binding to polymer derivatives would occur appear 
as negligible difference between the two data sets giving the unity correction ratio situation.  
The calculated correction ratios ranging from 2.1 to 1.9 were applied to the original cell 
numbers and resulted in an adjusted seeding value of 4.6 x106 ± 1.4 x106 cells, a maximum 
number of 84.2 x106 ±7.0 x106 cells at day 5, and a final day 7 time point resulted in 63.5 x106 
± 5.12 x106 cells. These corrected cell values supported the MTT results at day 5 which 
displayed an intense staining over a majority of the cross section (Fig. 4-1 B Run 1) and at 
day 7 the cross section showed staining but indicated occlusion in some regions (Fig. 4-1 B 
Run 1). Considering these corrected cell numbers an 18-fold increase was calculated in cell 
numbers over the range of five days. The feasibility of this proliferation rate involved 
analysing the cells used, 3T3 Swiss albino fibroblasts, especially the stated doubling time of 
18 hours provided by the supplier (ATCC, 2014). Calculations for a 2D environment beginning 
with an initial 4.5 x106 cells and doubling at 18 hours over a 5 day period resulted in 66.7 
x106 cells. The growth rates between 2D and 3D culturing environments have been reported 
to differ with a 3D environments reporting better cell growth over 2D conditions (Barralet, 
et al., 2005). The drip-perfusion bioreactor accommodated 3D cell proliferation and a 
difference of 24.2 x106 cells is a plausible value. An older study of long term perfused bone 
marrow mononuclear cell culture showed 10-fold increase within 14 days (Koller, et al., 
1993). Another study showed 3-fold increase over 4 days using PLLA-RGDC scaffolds 
culturing mesenchymal stem cells in a flow perfusion bioreactor (Alvarez‐Barreto, et al., 
2011). However, the results from existing literature involved dissimilar parameters such as 
bioreactor design and cell types with slower proliferation in contrast to this novel drip-
perfusion system culturing 3T3s.  
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In addition to cell calculations via DNA isolation, cell counting was also conducted on the 
medium extracted from the bioreactor systems culturing TIPS scaffolds. The medium 
extracted from the reservoir coincided to the time points: 3 hours directly after dynamic 
seeding, at 1 day and 2 days. The numbers calculated indicated 0.49 x106 ± 0.18 x106 cells 
present in the medium following dynamic cell seeding at 3 hours, 0.12 x106 ± 0.03 x106 cells 
at the 1 day time point, and 0.60 x106 ± 0.04 x106 cells at the 2 day time point. These 
calculated cell numbers from the chamber reservoirs were statistically tested with a one way 
ANOVA which depicted a significant difference amongst these time point samples (F2, 6 = 10.5, 
P = 0.01). Post-hoc analyses using student’s t-tests (P < 0.05) with a Bonferroni correction 
(Bonferroni, 1936; Wolfram Research, 2014) identified the significant difference between 
the cell count values of 1 day and 2 day time points, t(4) = 2.78, p = 0.0002. This suggested 
after dynamic seeding a non-significant decrease in cells was calculated, however from the 
1 day to the 2 day time point a significant increase in cells was calculated in the reservoir 
medium. This result indicated that the cells seeded after 3 hours decreased in numbers from 
the tapered reservoir suggesting the reduced flow rate from 3 mL/min to 1 mL/min assisted 
in delivering cells through the circulation loop and into the scaffold. Although between 1 day 
and 2 days of drip-perfusion culturing cell numbers significantly increased in the reservoir 
medium, which indicated a possible detachment of cells after 1 day of drip-perfusion 
culturing. The MTT results of the drip-perfused TIPS scaffolds indicated a progressive 
decrease in stained cell activity at the superior surface of the scaffolds (Fig. 4-1 B Run 1). It 
is plausible that the correlation between the significant increase in counted cells in the 
reservoir medium and decrease in MTT stained activity beneath the drip feed outlets, was 
attributable to the impact forces of the dripped medium mentioned previously and 
supported the theory of shear stress caused by the dripping culturing medium and affected 
cell adherence.  
The cell count assay performed after dynamic seeding (3 hours) resulted in values of 0.49 
x106 ± 0.02 x106 cells in the reservoir chamber and correlated with the 3 hour time point of 
corrected cell numbers calculated from DNA isolation of 4.6 x106 ± 1.4 x106. These combined 
cell values accounted for cell numbers ranging from 73% to 100% of the 5 x106 seeded into 
the culture. From the cells counted in the medium a corresponding value of 4.51 x106 cells 
or 90.2% of the cells would be located in the TIPS scaffold and in the medium circulation 
tubing. Considering a larger proportion of cells in the circulation loop would swiftly lead to 
blockages and as none were observed it could be postulated that a majority of the 3T3s were 
seeded or accumulated within the TIPS scaffold. Complementary to the seeding value of 
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90.2% ± 0.02 x106 cells, was the corrected cell number derived from DNA isolation at 92.5% 
(+7.5%|-28.0%). The correlation of calculations using two dissimilar protocols would support 
a seeding value of 91.4%.  
Cell number assays were also performed on reservoir medium removed from bioreactors 
culturing FDM scaffolds corresponding to time points 3 hours, 1 day and 2 days. The one way 
ANOVA showed no significant difference existing amongst the n = 3 samples (F2, 6 = 0.10, P = 
0.91). The values calculated 2.69 x106 ± 0.26 x106 cells were located within the FDM scaffold 
and the medium circulation loop. From these values it could be purported a seeding density 
of 53.8% ± 5.2% was possible. However, further investigation is required to assess the 
numbers of cells within the 3D cultures and to correlate with the existing data of the assayed 
medium; then an accurate calculation for seeding density of the FDM cultured scaffolds can 
be provided.  
The seeding values from FDM (53.8%) and TIPS (91.4%) scaffolds indicated feasible 
performances when compared to studies provided in literature utilising perfusion 
bioreactors; these studies showed seeding efficiencies of 15.3% to 88.6% which involved 
scaffolds fabricated from poly-Ɛ-caprolactone (PCL) to PLA to polyglycolic acid (PGA) 
(Alvarez‐Barreto, et al., 2011; Bartnikowski, et al., 2014; Kim, et al., 2000; Melchels, F. P., et 
al., 2011; Zhao & Ma, 2005). These reported perfusion bioreactors also used additional 
mechanisms to assist with cell adhesion such as arginine-glycine-aspartic acid peptides 
attached to PLA surfaces, surface etched PCL, bovine serum albumin in media and oscillating 
dynamic seeding where the direction of medium flow containing cells was alternated at set 
time intervals over a defined seeding duration (Alvarez‐Barreto, et al., 2011; Bartnikowski, 
et al., 2014; Kim, et al., 2000; Melchels, F. P., et al., 2011; Zhao & Ma, 2005). Our drip-
perfusion bioreactor used DMEM-FCS coated scaffolds, dripping medium and gravity driven 
perfusion to dynamically seed 3T3s with the average seeding efficiency outperforming the 
higher range of the perfusion bioreactors (91.4% > 88.6% (Kim, et al., 2000)) for TIPS 
fabricated scaffolds and a proposed estimate of 53.8% seeding efficiency in the FDM 
fabricated scaffolds.  
From the cell counting and DNA quantification results the cell numbers showed a high 
seeding value followed by proliferation in the TIPS scaffolds until day 5 of drip-perfusion 
culturing. Additionally a higher seeding value was calculated when dynamically seeding with 
a drip-perfusion bioreactor compared to a normal perfusion bioreactor.  
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The cell cultures produced by the drip-perfusion bioreactor were investigated for 3D cell to 
cell interaction. The FDM disc scaffolds were harvested at designated time points over a 28 
day culture and fluorescently stained for cell-to-cell and cell-to-scaffold behaviours. From 
the images it was shown that cell-to-cell structures occurred and involved PLA fibres being 
bridged by cells which in turn encouraged cell migration and proliferation within the region 
forming dense bridge-like structures. Furthermore it was proposed that these cell bridges 
expanded away from the PLA fibre junctions forming triangular shaped cell bridges towards 
the centre of the 4 mm2 pores of the FDM scaffolds. This suggested true 3D cell growth 
capabilities of the bioreactor design shown in time points week 2 to 4 in both discs 2 and 4 
(Fig. 4-9, 4-10 and 4-11). The imaged dense cell-to-cell structures were supported by the cell 
activity indicated by MTT staining of the FDM discs amongst related week 1 to 3 time points. 
These dense cell-to-cell structures formed suggested that the 3T3s created an ECM matrix 
that possibly adhered to the PLA fibres. Expressions of ECM proteins such as collagen I, 
collagen III and fibronectin by fibroblasts have been established in literature and have been 
noted as a precursory stage for cell-cell interactions (Eckes, et al., 1993; Eckes, et al., 2000; 
Lambert, et al., 1992; Mutsaers, et al., 1997). These dense 3D fibroblast cultures produced 
by the drip-perfusion bioreactor would provide an ECM foundation for examining cell-cell 
interactions in co-cultured 3D cell models. A proposed model would be skin related; 
fibroblasts being a constituent cell of the epidermis (Lenoir-Viale, 1996; Wang, et al., 2008) 
would provide the basis of integrating keratinocytes, melanocytes, microvascular 
endothelial cells or adipocytes in a three dimensional environment emulating native 
conditions. Consideration would also be required for the scaffold polymer selected as well 
as architecture.  
 
In conclusion this research has demonstrated that a simple, low cost drip-perfusion 
bioreactor was capable of viable cell culturing up to 28 days in large volume 3D constructs 
with seeding values of 92.5% for TIPS scaffold cultures and 53.8% for FDM scaffold cultures. 
It was noted that optimisation was still required for distribution of cells throughout the 
scaffolds and could be addressed by lessening the distance between the superior scaffold 
surface and drip feed tubes or redesigning the scaffold architecture. Scaffold redesign would 
also address preventing obstruction of routes for nutrient and gas delivery and removal and 
in turn prevent occlusion and internal necrosis of the scaffolds, making this the preferred 
option. Finally, the protocol for DNA isolation could be refined by optimising the NH4OH 
concentration correcting for underestimated calculations. This would provide an exact 
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calculation of cell numbers in the scaffold culture, information required when optimising cell 
cultures producing proteins.  
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5.0 General discussion 
The research conducted in this study was based on the hypothesis that a simply constructed 
and simply operated drip-perfusion bioreactor system could be inexpensive yet scalable in 
numbers, and produce viable and proliferative cell cultures that grew three dimensionally.  
To confirm this hypothesis three aims were derived and studies were conducted. Results 
from the first aim established a bioreactor design consisting of straightforward concepts 
involving drip and perfusion delivery of medium onto and into cell culture. The second aim 
of fabricating the design resulted in inexpensive construction techniques and feasible 
bioreactor components that kept the progress aligned with a rationale of simplicity. The final 
aim of validating the constructed drip-perfusion bioreactor provided insight into the actual 
functioning of the bioreactor design, flaws and the possibilities available for future work.   
The work conducted in this research project has provided current and future researchers 
with a novel tool for conducting viable and scalable 3D cell culturing studies at minimal costs 
for bioreactor systems. The key outcomes of the study have been provided in the following 
sections.  
 
5.1. Bioreactor design 
The bioreactor design was adapted and redesigned from an earlier version (Cao & Croll, 
unpublished 2010) to remove bulkiness while improving simplicity and handling. Scalability 
was factored into the design by examining and streamlining the sections dealing with 
medium and gas delivery, removal, and circulation. The drip-perfusion concept was 
maintained due to its straightforward application of gravitational and capillary forces to both 
drip medium from the outlets onto the cell culture surface and perfuse it into the 3D culture.  
Design upgrades were made to reduce bioreactor down-time while increasing ease of 
sterilisation and economy of use. These design concepts carried through the versions of the 
drip-perfusion bioreactor and into the latest fabrication of the system.  
The design upgrades involved: integrating the medium and gas delivery and removal routes 
into a single, compact bioreactor “head” for ease of autoclaving; suspending the 3D cell 
culture tray above a tapered chamber floor where any bulky debris would accumulate and 
settle rather than circulate and obstruct the circulation system; the medium return tubing 
being offset from the central axis of the chamber reservoir to assist with recirculating the 
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medium while not disturbing the accumulated debris; integrating a manual hand pump that 
could exert sufficient suction to remove waste medium and any unseeded cells/debris from 
the tapered chamber; introducing an air trap to prevent and capture bubbles in the drip 
tubes and basing circulation control on a 3-way valve junction.  
The latest drip-perfusion bioreactor design was fabricated and tested. The current drip-
perfusion design was sufficient for maintaining 3D cell culture within a fabricated scaffold 
up to 28 days. Optimisations to improve upon the remaining imperfections would be 
addressed in future work. 
 
5.2. Bioreactor fabrication techniques 
Fabricating the drip-perfusion bioreactor involved optimisation of several concepts. The 
techniques were performed using common equipment and inexpensive materials such as 
laboratory ovens and laboratory sourced components. The evolution of the drip-perfusion 
bioreactor developed techniques that showed potential such as mould casting with PDMS 
whereas other techniques required revisions such as the fabrication of the medium drip 
feeds. The first fabrication involved shaping blunt syringe needles and resulted in inaccurate 
construction which led to uneven pressure drop across these drip feeds, poor medium 
distribution and gas accumulation in the tubing. The subsequent version removed the needle 
shaping procedure entirely by using gas permeable tubing and reverting to the PDMS casting 
technique. PDMS mould casting was used to create a section of the air trap and cast the drip 
feed tubes in the bioreactor head. 
Another important fabrication process involved casting the PDMS bioreactor heads onto a 
base component. The issue of unsustained adherence of PDMS to PMMA components 
compromised sterility of the bioreactor system. Structural tears occurred and caused 
difficulty for comprehensive cleaning. From literature, Tan, et al. (2010) reported laminating 
with an adhesive then spin-coating PDMS onto the laminated acrylate components. A 
technique by  Harris, et al. (2007) coated a surface with poly-L-lysine before cured PDMS was 
attached. A third technique by Vlachopoulou, et al. (2009) used oxygen plasma to treat 
PDMS and a silane solution coated PMMA to create irreversible bonding between the two 
materials. However Tan, et al. (2010) technique would have been time consuming for 
fabricating multiple systems, Harris, et al. (2007) bonding technique was reversible and 
Vlachopoulou, et al. (2009) technique required a reactive ion etching reactor, not readily 
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available. Instead the PMMA components were replaced with medical grade stainless steel 
which bonded to PDMS without the previous complications as well as making the bioreactor 
head autoclavable.   
Withdrawing medium from the system initially involved a syringe combined with a check 
valve and Y-shaped adapter enclosed in a plastic bag. Although this combination was 
inexpensively sourced and simply connected into the system the handling of the syringe 
within a plastic bag was difficult. This combination was replaced with a Jackson-Pratt drain 
simplifying the components required for the system for a small cost. Additionally the 
reduction in the number of working joints decreased the down-time for cleaning, 
resterilising and reassembling the bioreactor system.  
The remaining fabrication of the bioreactor was straightforward with the majority of tubing, 
adapters, valves and stopcocks requiring interconnection. The total cost for fabricating one 
system was calculated at under $215.00 AUD, and the total fabrication cost for 6 chambers 
was under $1300.00 AUD. In comparison a 6 chambered bioreactor system offered by Sigma-
Aldrich, retails at $26,100 AUD for a 6 chamber 3D cell culturing, perfusion design (Sigma-
Aldrich Co. LLC., 2014). The system provided by Sigma-Aldrich is 20 times the price of our 
fabricated system. 
As the majority of the components used were inter-connectable, adapting the design for an 
inline component for monitoring a specific factor, such as pH levels in the medium could be 
easily accommodated. Examples of a compatible component are the EasyFerm Arc 425 and 
the OxyFerm FDA Arc 425, commercial sensors which can be installed into the medium loop 
to gauge a pH and diffused oxygen respectively available through Hamilton Co. Pty. Ltd., USA 
(Pharmamanufacturing, 2014).  
 
5.3. Bioreactor validation  
Validating the functionality of the drip-perfusion bioreactor found the design was feasible 
for 3D cell culturing. Results showed initial cell numbers reaching a maximum of 43.7 x106 ± 
5.43 x106 within five days of culture from a seeding number of 5 million cells in a 96% 
porosity 5.4 mL TIPS fabricated scaffold. However it was shown that efficacy of the DNA 
isolation protocol was lower in yield than expected and it was proposed that a significant 
underestimation of cell numbers was calculated. A ratio was calculated to correlate values 
between DNA isolated from cells and cells mixed with scaffold samples. Applying this 
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correction ratio resulted in a seeding value of 4.63 x106 ± 1.4 x106 cells and a maximum of 
84.2 x106 ± 7.0 x106 cells at day 5.  
Similar 3D cell culturing studies using a perfusion bioreactor system showed that bone 
marrow mononuclear cells saw a 10 fold increase within 14 days (Koller, et al., 1993). Our 
latest drip-perfusion bioreactor system indicated cell proliferation of 18 fold increase over 5 
days in TIPS scaffolds cultured with 3T3s. MTT staining data from the cultured FDM disc 
stacks suggested the high density cell cultures which could be applicable for protein 
production and tissue engineering research (Langer & Vacanti, 1993; Martin, et al., 2004; 
Sørensen & Mortensen, 2005; Soufi, et al., 2012).  
Additionally the seeding rate in TIPS fabricated scaffolds was calculated at 91% and a 
proposed estimate of 54% for the FDM fabricated scaffolds. When compared to the 15% 
(Zhao & Ma, 2005), 35% (Bartnikowski, et al., 2014) and 89% (Kim, et al., 2000) rate of 
dynamically seeded perfusion bioreactors, the results from the drip-perfusion system scored 
towards the upper range for FDM dynamic seeding and exceeded the upper range for 
dynamic seeding in TIPS scaffolds. The non-uniform MTT staining within the superior surface 
regions in both cultured TIPS and FDM scaffolds suggested that gravitational forces exerted 
by dripped medium inhibited cell to scaffold adherence during seeding and culturing. 
Literature provided examples of shear stress forces required for 3T3 detachment from 
various substrates (Bundy, et al., 2001; Weder, et al., 2010), although substrates in these 
studies were not representative of the PLA and PDLLA polymers used in validating the drip-
perfusion bioreactor herein. It was suggested that this problem could be addressed by 
redesigning the scaffold architecture to minimise the forces experienced or by lifting the 
scaffold support tray to a position to lessen the impact forces from the dripping medium 
onto the cells in the scaffold.  
MTT results also suggested the cultures reached a critical cell density by day 6 to 7 and week 
3 to week 4 in the TIPS and FDM fabricated scaffolds respectively. Analysis of the data 
suggested that 3T3s in culture had proliferated to a critical cell density and occlusion had 
begun within pores located in the central scaffold regions. Our findings of occlusion and 
proposed necrosis within internal scaffold regions were consistent with literature where a 
200 to 400 μm vessel proximity was necessary for cells to obtain nutrients and gas exchange 
(Auger, et al., 2013; Carmeliet & Jain, 2000; Rouwkema, et al., 2008). 
Fluorescent staining of cell nuclei and cytoskeleton of 3T3s cultured within PLA FDM discs 
suggested three dimensional cell growth as well as the expected surface cell growth on the 
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PLA fibres. The indicated 3D dense cell structures commonly bridged sections of the 4 mm2 
disc pores. The interpretation that these were dense cell bridge-like structures, visualised by 
fluorescent microscopy, was supported by MTT staining (cell activity) within the FDM discs. 
The implications that these dense fibroblast structures could be expanded to 3D cell co-
culturing models related to skin where fibroblasts are a key cell found in the epidermis and 
provides deposition of ECM proteins to support other cell types such as keratinocytes 
(Lenoir-Viale, 1996; Marionnet, et al., 2011; Wang, et al., 2008).  
 
5.4. Conclusion 
The design, fabrication and testing of our Version 3 drip-perfused bioreactor system resulted 
in viable 3D mammalian cell culture that was maintained for 28 days with no contamination 
observed during medium changes.  
5.4.1. Future bioreactor use considering protein expression experiments 
With regards to high density cell cultures previous applications include recombinant 
antibody expression from hybridomas (Casablancas, et al., 2013; Jain, et al., 2011) and 
protein expression from CHO cells, mouse myeloma (NS0), baby hamster kidney (BHK), 
human embryo kidney (HEK-293) and human retinal cells (Kim, et al., 2012; Wurm, 2004). 
Although our drip-perfusion bioreactor was not cultured with hybridomas the MTT and 
fluorescent staining results of high density culture of mammalian fibroblasts indicated 
potential. For high density cell culturing using scaffold architecture similar to the FDM disc 
stacks would be advantageous and would allow a continuous culture for 3 to 4 weeks 
without passaging. Prolonging this process could involve a simple approach of aseptically 
removing the inferior most located disc approaching critical density and replacing it with a 
fresh disc on the stack’s superior most location. Complete removal and renewal of medium 
every two to three days would allow for purification of expressed proteins within the 
collected medium. This situation would expect the cultured cells to be capable of 
synthesising and utilising a signal sequence for the N-terminal of the target protein and 
eventual protein secretion into the medium for purification (Blobel & Dobberstein, 1975; 
Hegde & Bernstein, 2006). To efficiently isolate protein from the medium, preceding and 
proceeding protocols to drip-perfusion culturing are proposed and can involve, respectively, 
engineering an affinity tag into a specific location in the target protein sequence and 
isolation of recombinant protein by exploiting the binding efficiency of the affinity tag via a 
chromatography technique (Gräslund, et al., 2008). Various affinity tags and their 
 Chapter 5:General discussion  109 
corresponding benefits and disadvantages have been reviewed ranging from the smaller 0.8 
kDa polyhistidine and polyarginine tags to the larger 20.0 kDa tags of glutathione S-
transferase and could provide initial points of research for the unfamiliar investigator 
(Gräslund, et al., 2008; Terpe, 2003).  
Protein production in the drip-perfusion bioreactor is anticipated to experience difficulties 
when aiming to produce ECM related proteins. Although current commercial sources of ECM 
proteins such as collagen I, IV, fibronectin and vitronectin are derived from mammalian 
sources including rat tail tendons, human placenta, and human plasma instead of being 
recombinantly produced, due to the complexity of interplay between genes, enzymes, 
proteins and cofactors involved in their respective syntheses and PTMs (Canty & Kadler, 
2005; Myllyharju & Kivirikko, 2004). Recent advances in molecular engineering have 
provided an approach to recombinant collagen production using plant cells (Shoseyov, et al., 
2013) and may be provide translatable techniques for use with the drip-perfusion bioreactor. 
The design of the drip-perfusion bioreactor utilised a scaffold to support adherent cell 
culture which relied on their deposition of ECM proteins to bind to the functionalised 
scaffold. The type of functionalization and amount of scaffold surface treated requires 
consideration as literature reported increased migration impingement proportional to 
surface area functionalised (Mann, et al., 1999; Mann & West, 2002). This impinged 
migration would impact on the uniformity of scaffold cell culture and possibly hinder cell 
proliferation rates due to dense cell population in confined regions. Examining different 
parameters of scaffold surface functionalization with respect to a selected cell type for ECM 
protein production would be necessary when investigating this procedure in the drip-
perfusion bioreactor. 
The second consideration with ECM protein production is the method of extracting secreted 
ECM protein from within an adherent cell culture. A possible approach could involve the use 
of magnetic particles/beads, diameter of 1-4 μm, coated with an affinity ligand capable of 
binding the affinity tag engineered into the target protein. Although literature has shown 
success purifying peptidases, polysaccharide hydrolases, albumin and peptides with the 
magnetic separation technique when applied to cell lysates (Safarik & Safarikova, 2004) and 
novel optimisations have been performed to increase purification yields (Xu, F., et al., 2011) 
this magnetic separation technique would require adaptation and optimisation when used 
for purifying ECM proteins. This magnetic technique could be applied to this drip-perfusion 
system by injecting magnetic particles into the media circulation loop (Fig. 3-8 B, 2i) prior to 
the air trap via an integrated 3-way stopcock, the circulating medium would carry the 
particles to the drip feed outlets and drip-perfuse them through the cell culture. The affinity 
  
110  Chapter 5: General discussion 
ligand coated magnetic particles would be expected to bind affinity tagged protein as the 
particles were transported throughout the scaffold by the medium (Fig. 5-1). The medium 
containing the protein bound particles could then be extracted from the reservoir with the 
manual hand pump and a magnetic separator applied to the harvested medium yielding the 
protein bound particles. These particles could be treated with an enzyme cleaving the 
affinity tag and isolating the desired protein. This procedure could be performed to coincide 
with medium exchange intervals reducing an accumulation of magnetic particles in the cell 
culture.  
   
Figure 5-1 Schematic of drip-perfused medium carrying magnetic particles coated with 
affinity ligands 
The magnetic particles would be carried through the scaffold by the perfusion of medium and 
collected after medium extraction using a magnetic separator. Particles trapped due to dense 
cell culture would involve sacrificing the cultured scaffold, lysing the cell culture and separating 
the magnetic particles via magnetic attraction.  
 
If the density of the cell culture had approached critical cell density, the FDM disc stack may 
need to be sacrificed for protein purification. Magnetic particles lodged within the cultured 
scaffold could be used advantageously after lysing the adherent cell culture with a chemical 
approach for example RIPA (radio-immunoprecipitation assay) buffer,  M-PER (Mammalian 
Protein Extraction Reagent) solution and T-PER (Tissue Protein Extraction Reagent) solution 
(Thermo Fisher Scientifc Inc., 2014); post cell lysis the magnetic particles binding target 
Adherent cell culture 
Medium flow 
Magnetic particles coated 
with affinity ligands 
PLA FDM scaffold 
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protein, could be separated from the lysate using the magnetic separator as reported in the 
literature (Safarik & Safarikova, 2004). Although these methods are proposed optimisation 
would be anticipated for each protocol during the endeavour of investigating high yields of 
produced protein.  
5.4.2. Future bioreactor use considering tissue engineering experiments  
In addition to protein production our drip-perfusion bioreactor is a tool applicable for tissue 
engineering purposes where adherent cells are commonly grown in 3D scaffolds 
(Bartnikowski, et al., 2014; Cao, et al., 2005; Wang, et al., 2013). The ability of the drip-
perfusion system to handle different scaffold architectures due to its free platform could 
provide a testing environment for biomaterials with combinations of different architectures 
and different cell types. Currently the field of study involving scaffolds encompasses 
biomaterial selection, related fabrication techniques, functionalization and applicable uses 
in specific research niches such as osteogenesis, chrondrogenesis, recelluarisation and 
ophthalmic tissue engineering (Bray, et al., 2012; Farrugia, et al., 2013; Gredes, et al., 2012; 
Harkin, et al., 2011; Hutmacher, 2000; Li, et al., 2005; Miyagi, et al., 2011). The drip-perfusion 
bioreactor design would be capable of tissue engineering in small volume scaffolds by 
adapting the head of the bioreactor and the chamber to smaller dimensions. Additionally, 
the ability to improve the design by integrating another circle of drip feed outlets could be 
accommodated. However, large volume scaffold tissue engineering would encounter 
occlusion issues as suggested by the MTT staining results presented in Section 4.3.1.1 and 
4.3.2.2.  
Regarding possible occlusion difficulties with large 3D tissue engineering models it would be 
practical to consider introducing complementary nutrient and gas delivery routes into the 
dense cell culture, preferably before critical cell density occurs. As reported in the literature 
associated with vasculogenesis and angiogenesis, the diffusion of gas and nutrient from the 
natural delivery routes, blood vessels, into surrounding tissue is averaged at 200 μm 
(Carmeliet, 2000) and when correlated with in vitro large 3D model tissue engineering 
without sufficient provision of fresh resources and the removal of metabolic waste the  non-
supplied cells succumb to necrosis, causing the cultured construct to fail over time 
(Rouwkema, et al., 2008). Encouraging a blood vessel network into the cell culture model 
would be a solution representative of a natural tissue niche. One such approach includes 
adapting the in vivo arteriovenous (AV) loop (Beier, et al., 2010; Fiegel, et al., 2010; Kneser, 
et al., 2006) into an in vitro AV loop through the scaffold. This would comprise a secondary 
pump driving nutrient and gas enriched medium through the AV route and the loop itself 
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would be capable of diffusing these resources into the surrounding cell culture. The physical 
loop material could be a permeable membrane created by a single or combination of 
biomaterials as the loop would require structural support allowing medium to pass through 
the loop while withstanding pressures instigating collapse by proliferating adherent cells. 
One such combination could use PLA as an inner cylindrical frame support, due to its robust 
properties demonstrated in the fluorescent staining results (Section 4.3.2.3) where high 
density adherent cell culture was supported, and an outer membranous biomaterial such as 
fibroin or sericin derived from silk of Bombyx mori, reported as a membrane substrate for 
the culture of corneal epithelial cells (Chirila, et al., 2013; Minoura, et al., 1990). Alternatively, 
a single biomaterial such as PLLA could be used with two protocols to fabricate the 
membrane and the internal support architecture (Hutmacher, 2000; Zhu & Chan-Park, 2007). 
The adaptability of the drip-perfusion bioreactor design would allow multiple AV loops to be 
integrated into the bioreactor head. This could be achieved by 3D printing a scaffold to 
include channels designated for insertion of these hybrid biomaterial AV constructs which 
would interconnect to extra feed outlets, in the form of gas permeable silicone tubing cast 
into the bioreactor head (Fig.5-2). From the bioreactor head, the tubes could be fed by a 
main tube with an integrated air trap and connected through the second peristaltic pump 
creating a secondary medium loop. The scaffolds could then be populated with an adherent 
cell type capable of ECM protein deposition, for example mesenchymal stem cells or 
fibroblasts (Hansmann, et al., 2013; Pittenger, et al., 1999; Sikavitsas, et al., 2002), while a 
secondary cell type preferably angiogenesis related endothelial cells or perivascular cells 
(Eichmann & Simons, 2012; Hirschi & D'Amore, 1996; Lamalice, et al., 2007; Li, et al., 2011; 
von Tell, et al., 2006) could be seeded into the AV loop biomaterial structure promoting 
vessel sprouting into the scaffold to service the surrounding culture.   
An alternative could include fabricating porous TIPS scaffolds containing distributed large 
sized pore channels, over 500 μm in diameter to limit occlusion by cell proliferation and 
simulating the channels discussed above. This could be achieved by inserting pins into the 
EC-PDLLA solution while crystallisation occurs, subsequently the pins are removed and a 
negative volume would define these large sized pore channels. Although, this approach 
would be not be as straightforward to supply a secondary medium or as accurate to seed a 
secondary cell type this method would reduce investigation complexity with the removal of 
the AV loop and its related parameters.  
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Figure 5-2 Schematic of the drip-perfusion bioreactor head integrated with tubing 
emulating  arteriovenous (AV) loops 
The adaptable design of the bioreactor head allows for integration of secondary components to 
investigate prolonging three dimensional (3D) cell culturing within the system. Nutrients and gas 
enriched medium is circulated through the inner regions of the scaffold via fabricated channels 
and is returned through biomaterial tubing connected to a silicone return tubing. The scaffold 
channels can be fabricated by integrating these negative spaces into the 3D printing design. The 
biomaterial tubing can be fabricated from a flexible membranous material including sericin, 
fibroin or a polymer combination.   
 
 
 
The use of decellularised tissues could be a third alternative for inducing formation of a 
vessel network into 3D co-culturing examining organ regeneration within the drip-perfusion 
bioreactor. This process would involve removing cellular material from a tissue or organ 
sample with the aid of a detergent leaving an ECM containing unstripped proteins and 
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growth factors (Ott, et al., 2008; Uygun, et al., 2010; Wang, et al., 2011). Upon  reseeding 
these ECM skeletons with similar cell types to the original tissue, these remanent 
compounds act as cues for angiogenesis via chemotaxis with typical promoters being 
vascular endothelial growth factor, basic fibroblast growth factor (Ferrara, 2009; Lamalice, 
et al., 2007) and angiopoietins, and haptotaxis promoted by integrins of differing  α and β 
subunits bound to ECM proteins (Giancotti, 2000; Liu, et al., 1999). This recent technology 
has reported preliminary success from repopulating mouse hearts demonstrating a cardiac 
pulse (Lu, et al., 2013), recelluarised rat lungs displaying 6 hours of capability when 
implanted in vivo (Ott, et al., 2010) and recelluarised rat liver which was transplanted and 
trialled for 8 hours in vivo before analysis (Uygun, et al., 2010). Further work in these and 
related areas are required to regenerate long lasting tissue and organ replacements and the 
drip-perfusion bioreactor system can be utilised by new investigators. The adaptability of 
the design coupled with the results herein provide a validated tool for tissue and organ 
regeneration studies.  
 
In conclusion our drip-perfusion bioreactor was designed, fabricated and tested using 
inexpensive components and techniques, was scalable in system numbers and importantly 
produced viable cell cultures. The designed system was capable of sustaining true three 
dimensional cell cultures that proliferated over 28 days. These results indicated potential for 
protein production using a continuous cell culture model, tissue engineering applications 
with assistance of integrated nutrient and gas routes, and examining intricate co-cultured 
cell models. This drip-perfusion bioreactor is a promising researcher’s tool, advantageous 
and applicable to current bioreactor related research.  
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Appendices 
5.5. Supplementary material 
The following files are the digital products for fabricating the drip-perfusion bioreactor 
components and the scaffold sectioning jig. These files are ready for metal or acrylic 
fabrication using CAD software. 
The AutoCAD and CorelDraw files are located at the following online addresses: 
The accompanying password to these files is: BioreactorV3 
 CAD2000_v4Acr-MouldLayers12.dwg  
https://fileshare.qut.edu.au/public/leungl5/LeoQUT_CAD2000_v4Acr_MouldLayers12.cdr   
 CAD2000_v4Acr-MouldsLayers345.dwg  
https://fileshare.qut.edu.au/public/leungl5/LeoQUT_CAD2000_v4Acr_MouldsLayers345.cdr  
 
 CAD2000_v4SS-ArmsBasesTrays.dwg  
https://fileshare.qut.edu.au/public/leungl5/LeoQUT_CAD2000_v4SS_ArmsBasesTrays.cdr   
 ScaffoldJigHandleV14.cdr  
https://fileshare.qut.edu.au/public/leungl5/ScaffoldJigHandleV14.cdr   
 ScaffoldJigV14.cdr  
https://fileshare.qut.edu.au/public/leungl5/ScaffoldJigV14.cdr  
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